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SUMMARY
The enzyme responsible for catalysing the oxidation-reduction of the 
11-oxygen functions of steroids is 113-hydroxysteroid dehydrogenase 
(118-HSD). Previous physiological and histochemical studies have shown 
that the enzyme occurs in salivary gland, as demonstrated by the conversion 
of cortisol to cortisone in significant quantities. The aims of this 
thesis were to report more fully on the investigation of ll^-rHSD in rat 
submandibular gland.
A reverse isotope dilution technique using cortisol-4-’^ ’C as substrate 
was used to assay the enzyme in homogenate, spectrophotometric and fluoro- 
metric assays being unsuitable. Cortisol was converted to cortisone, as 
identified by formation of cortisone derivatives and recrystallisation to 
constant specific activity.
A variety of assay parameters were investigated to find the optimal 
conditions of enzyme activity. Nicotinamide adenine dinucleotide was the 
preferred cofactor to nicotinamide adenine dinucleotide phosphate with the 
optimal pH conditions for the cofactor-linked enzyme being pH8.1-8.9 and 
pH7.6 respectively. Both cofactors were in saturating amounts at 1.25mM 
in the assay volume of 11ml. A phosphate buffer showed no side effects 
whereas borate and tris buffer showed chemical reactions and therefore 
phosphate buffer was used to control pH. The optimal temperature for the 
NAD- and NADP-linked llg-hydroxysteroid dehydrogenase was 37°C for 
incubations of 2 mins. and 7 mins. respectively. Km and Vmax values for 
the NAD-linked 118-hydroxy steroid dehydrogenase were 0.48yM and 1.27 n moles/ 
min., the NADP-linked 118-hydroxysteroid dehydrogenase values being 0.95pM 
and 0.37n moles/min. The substrate concentration chosen for enzyme assay 
was approximately 2xKm of the NAD-linked enzyme. Verification of enzyme 
assay for lOOmg gland homogenates was shown by increasingly proportional 
enzyme activity with enzyme (gland) concentration around this value.
Reversibility of the reaction using cortisone-4-"^C as substrate 
could not be shown although reduced cofactors and a variety of pH values 
and incubation periods were used. One of the effects of 113-HSD in 
salivary gland is, therefore, to convert physiologically active steroids 
into inactive steroids by ll$-hydroxyl group transfer to 11-oxo group 
steroids.
Corticosterone, the naturally secreted adrenocorticoid in the rat, was 
metabolised by the submandibular gland II3-HSD.
Rat kidney was also used to investigate 113-hydroxysteroid dehydrogenase 
activity. The conversion of cortisol to cortisone was confirmed but using 
cortisone as substrate it was converted to a product other than cortisol 
thus indicating the difference between kidney and salivary gland metabolism 
of cortisone.
The intracellular localisation of 113-hydroxysteroid dehydrogenase 
was studied by incubating subcellular particles of the rat submandibular 
salivary gland for the NAD-linked 113-hydroxysteroid dehydrogenase. The 
subcellular particles were isolated from homogenate by differential 
centrifugation in sucrose. The main enzyme activity was found in the 
crude nuclear fraction and this led to the investigation of what part of the 
nuclear fraction was responsible for the enzyme activity. Nuclei were 
isolated using 1.8M Sucrose and these were found to retain the major enzyme 
activity. Attempts to solubilise the nuclear enzyme using detergent and 
hypotonic media were unsuccessful. It is of interest to see that the 
enzyme is nuclear bound as the liver enzyme has been located in the micro­
somal (I05,000g/hr.) fraction. The enzyme in the salivary gland may 
influence nucleic acid metabolism. However, further work will have to be 
undertaken to investigate this possibility.
It was recognised that the rat submandibular gland was a tissue of 
differentiated cell types. In the study of II3-hydroxysteroid dehydrogenase 
it was considered important to investigate the activity of the steroid
enzyme in separated tubules using the enzyme, collagenase, to break up the 
gland. However, little activity was recovered in the tubules probably 
because the collagenase used included a number of protease and peptidase 
impurities.
The histochemical localisation of the enzyme was in the duct cells.
It was not located in any single component of the salivary duct system but 
was evident in striated, lobular and interlobular excretory ducts. Acinar 
tissue did not exhibit any activity. Enzymes involved in central metabolic 
pathways were present principally in the ducts whereas alkaline phosphatase 
was present in the acinar tissue and not in the duct system. Acid 
phosphatase appeared in equal amounts in both the acinar and ductal tissue. 
The presence of these enzymes gives further proof of the concept of a highly 
active metabolic duct epithelium.
The culture of salivary gland ducts was investigated but no II3- 
hydroxysteroid dehydrogenase activity was present in cultures which were 
7 days and 3 weeks old. The enzyme may require the addition of various 
cofactors and hormones which are lacking in the tissue culture.
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GENERAL INTRODUCTION
-  1 -
GENERAL INTRODUCTION
1. llB-Hydroxysteroid Dehydrogenase.
In the early 1950's, several groups of workers studied the metabolism 
of cortisone and cortisol in man and other mammalian species which gave 
evidence for the probable existence of an enzyme catalysing the oxidation 
of the llB-hydroxy functions of naturally occurring steroids (Mason, 1950; 
Burton et al., 1953)• Cortisol and corticosterone were identified as the 
major glucocorticoid secretory products of the mammalian adrenal cortex, 
whereas cortisone and other 11-oxo group steroids were predominant in 
human urine. Cortisone was also found in large quantities in the urine 
of patients suffering from Cushing's syndrome in which large doses of 
cortisol were being secreted. Morris & Williams (1953) were, however, 
the first to suggest that cortisone might arise by the peripheral oxidation 
of cortisol, having found that small quantities of cortisone were detectable 
in the peripheral blood.
In subsequent years a large number of studies have been done to 
establish the properties and behaviour of the enzyme responsible,
11 B-hydroxysteroid dehydrogenase (llg-HSD). Fish et al. (1953) and 
Caspi et al. (1953) reported the presence of llB-HSDin porcine, bovine 
and rat liver preparations. Mahesh & Ulrich (i960) centrifuged the 
particulate fraction from a rat kidney homogenate at 104,000g for 1 hour 
and showed that the enzyme activity was found mainly in the nuclear 
particles and microsomes. By addition of 5x10 NADP (nicotinamide 
adenine dinucleotide phosphate) they increased the yield of cortisone from 
cortisol thirteenfold. They found that the system was not freely 
reversible. However, Hurlock & Talalay (1959) found that the microsomal 
11B-HSD of rat, guinea pig and bovine liver carries out the reaction 
reversibly with NAD (nicotinamide adenine dinucleotide) or NADP approxi­
mately equally effective as cofactors. They were the first to obtain a 
fairly highly purified 113-HSD by using acetone-dried powders of microsomes
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from rat livers. Their preparation was not soluble, although it needed 
centrifuging at 105,OOOg to sediment the enzyme. Sweat & Bryson (i960) 
found in mouse muscle an 113-HSD whose activity was inhibited by NAD, 
whereas NADP increased the activity. NADP(H2) was found to be the preferred 
cofactor for the 113-HSD1s found in rat liver and kidney (Mahesh & Ulrich, 
I960), rat brain (Grosser & Bliss, 1966), rat lung and testis (Koerner, 1966), 
human placenta (Osinski, i960), human liver (Meigs & Engel, 1961), and 
human skin (Hsia & Hao, 1966). Other sites of 113-HSD activity reported 
are in the murine thymus (Dougherty et al., i960), the wall of the small and 
large intestine of the rat (Stahl & Tapley, 1963)* and human testicular 
tumour tissue (Smith et al., 1964).
Bush et al. (1968) demonstrated that the relative substrate efficiencies 
and Km values of the enzyme were similar in whole (debris-free) homogenates, 
washed microsomes and acetone-dried powders of washed microsomes of rat 
liver. They reported that the optimal pH for the oxidative reaction of 
the liver microsomal 113-HSD was pH9 - 9.15. The optimal pH reported by 
Koerner (1969) for the cortisol 113-HSD in liver microsomes was pHlO.
Most other workers have chosen their assays to be carried out at the 
•physiological* pH7.4«
Peterson and his coworkers (1955* 1957) demonstrated that cortisone 
and cortisol were rapidly interconverted in normal humans, whereas one 
steroid analogue, 2<*-methylcortisone, and its related ll$-hydroxylic 
derivative were not interconvertible in the same way. Glenn et al. (1957) 
made similar findings using rat liver preparations in vitro. Bush and 
coworkers (1959* 1968) have shown with man in vivo, and with rat liver 
microsomes in vitro, that 113-hydroxysteroids and 11-oxosteroids with a 
trans A/B ring fusion are a structural requirement for 113-HSD enzymic 
activity.
113-HSD activity can be demonstrated histochemically (Baillie et al., 
1965c) and is present in two categories of tissue; firstly, where this
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activity coexists with several other hydroxysteroid dehydrogenases and, 
secondly, where it is present to the exclusion of all other hydroxysteroid 
dehydrogenases. The first group is exemplified by the adrenal cortex 
(Caiman et al., 1966; Hart et al., 1966) and in this instance the 113-HSD 
is thought to be involved in general steroid biosynthesis and metabolism. 
With regard to the second group, the specific tissue sites where 113- 
hydroxy steroids are utilised only are rat salivary gland ducts (Ferguson, 
1967), renal collecting tubules (Baillie et al., 1965a; Baillie et al., 
1966a), epididymal epithelium (McGadey et al., 1966), and certain placental 
membranes (Ferguson & Christie, 1967); each of these epithelial tissues 
is also considered to be involved in water and electrolyte transfer.
Baillie et al. (1965b) demonstrated weak 113-HSD activity in the 
sebaceous glands from areas prone to acne vulgaris, along with strong 
A^-33-, 163- and 173-HSD activity in the same region. Human and murine 
Leydig cells (Baillie et al., 1965c) utilised 113-hydroxyandrostenedione 
and 113-hydroxyprogesterone as substrates of choice for II3-HSD activity 
while moderate 113-HSD activity was apparent consistently in human inter­
stitial cells (Baillie & Mack, 1966). The enzyme has also been histo- 
chemically demonstrated in mouse ovary and human placental trophoblast 
(Baillie et al., 1965c), kidney and liver (Baillie et al., 1965a), and 
mouse kidney and thymus (Hoyer & Andersen, 1970). Ferguson (1967) and 
Ferguson et al. (1970) studied cortisol utilisation by salivary glands, 
kidneys, and adrenals of various mammals by using a standard histochemical 
technique for the demonstration of hydroxysteroid dehydrogenase and found 
no obvious relationship between the levels of II3-HSD activity in either 
of the tissues. Neither was the presence of 113-HSD in salivary glands 
particularly associated with mucous or serous secretion, nor were sex 
differences in levels of activity evident. They reported that nrat 
submandibular gland homogenates converted cortisol to cortisone in 
significant quantities11. (This gland can also be called the submaxillary 
gland.) Shannon & Prigmore (i960) described the presence of free
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(non conjugated) 17-hydroxycorticosteroids (17-OHCS) in human parotid 
fluid before and after oral administration of synthetic adrenocortical 
analogues. They suggested that parotid fluid could be used as a medium 
to determine human adrenocortical status. Katz & Shannon (1964) reported 
that cortisol to cortisone transfer in dog parotid tissue was indicative 
of 113-HSD in salivary gland tissue.
2. The Hydroxysteroid Dehydrogenases.
The hydroxysteroid dehydrogenases act by carrying out stereospecific 
conversions of hydroxyl and oxo groups with the addition, or removal, of 
hydrogen atoms using cofactors, NAD or NADP. The enzyme is named 
according to the number of the C-atom in the steroid nucleus to which the 
attacked hydroxyl group is attached and it is necessary to stipulate 
whether this hydroxyl group is on the «- or 3- face of the steroid molecule. 
The position at which hydroxysteroid dehydrogenases are active are 3®-? 33-, 
6 ° - , 63-, 70C-, 73-, 113-, 16«-, I63-, 17*-, 173-, 20<*-, 203- and 21-.
Reviews have been written on several of these enzymes by Talalay (1962) and 
Dorfman & Ungar (1965). The histochemical documentation of these enzymes 
has been reported by Baillie et al. (1966b).
A. 30C-Hydroxysteroid Dehydrogenase.
Whether this enzyme is obtained from bacterial or mammalian sources 
it is specific for the S^-hydroxyl function of 5*- and 53“ steroids.
Talalay & Marcus (1965) were able to isolate a soluble NAD-linked 3°c-HSD 
from Pseudomonas testosteroni that utilised various steroid substrates.
From mammalian sources Ungar & Dorfman (1954) and Tomkins & Isselbacher 
(1954) isolated the enzyme. Tomkins (1956) reported that the enzyme was 
in the soluble fraction of rat liver and the hydrogen acceptors could be 
either NAD or NADP. Dorfman & Ungar (1965) state that the enzyme occurs 
in rat liver, kidney and testis but not in lung, spleen, muscle or brain. 
Histochemically the enzyme will utilise androsterone and aetiocholanolone.
In rat ovarian corpora lutea a strong 3“- * ^  exists which appears to 
utilise S^-steroids preferentially (Baillie et al., 1966b).
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It has not been possible to separate completely mammalian 3tr-HSD from 
33-HSD. Hurlock & Talalay (1958) could not separate the activities even 
after extensive purification. Hurlock & Talalay (1959) ascribed to the 
enzyme a transhydrogenase function.
B. 3 B-Hydroxysteroid Dehydrogenase
This is a collective title which includes a A^-33-HSD, a A^-3B-HSD, 
a 30-HSD and a 3 (or 17) 3 -HSD.
The first enzyme, A^-33-HSD, is concerned with steroid biosynthesis. 
Samuels et al. (1951) used both C-^ and steroids and found the enzyme 
present in ovarian, testicular, adrenal and placental tissue which ir­
reversibly converts A^-SB^-hydroxysteroids to A^-3-oxo group steroids.
This enzyme, which is involved in a critical step in the sequence of 
biosynthetic reactions required to produce circulating corticosteroids from 
cholesterol in the adrenal cortex, involves the conversion of the pregne­
nolone, which is formed in the mitochondria (Koritz, 1968), into progesterone 
via 3 3-oxidation and A'^-isomerisation (Talalay, 1957). The first, and 
rate limiting, reaction is catalysed by 3B~^D (33-hydroxysteroid-NAD 
oxidoreductase; EC 1.1.1.51) (Neville & Engel, 1968). According to 
Beyer & Samuels (1956), the reaction is NAD mediated and occurs in the 
microsomal fraction of ox adrenal homogenate. McCune et al. (1970) and 
Basch & Finegold (1971) have found the enzyme present in the mitochondria 
of rat adrenal homogenate, and postulate the relationship of this enzyme 
system to the movement of steroid molecules. Histochemically (Baillie 
et al., 1966b) the reaction will develop in some tissues with NADP.
Rosner et al. (1965) and Katkov et al. (1972) have found ^ - 33-HSD activity 
in rat and boar salivary glands respectively.
The second enzyme is A^-33-HSD. Dorfman & Ungar (1965) noted that 
this enzyme along with A^—3“—HSD which have been found in liver and testis 
(Ungar et al., 1957; Grosso & Ungar, 1964) convert A^-3-hydroxy steroids 
to the A^-3-oxo group. The activity may, however, be due to the action of 
other contaminating HSD1s.
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The third enzyme, 33-hydroxysteroid dehydrogenase, is supposed to occur 
in mammalian liver. It is involved in the reversible oxidation of the 
33-hydroxyl group to the 3-oxo group of 5<^ - and 53- steroids. It was 
obtained by Rubin & Strecker (1961) in the microsomal and soluble fractions 
of mammalian liver. The histochemical utilisation of various saturated 
33-hydroxysteroids has, however, been studied in detail by Baillie et al. 
(1966b). Baillie & Mack (1966) and Koide & Mitsudo (1965) have noted a 
formazan deposit in testicular Leydig cells and placental trophoblast 
respectively, when incubated with saturated 33-hydroxysteroids and nitro 
blue tetrazolium.
The fourth enzyme, 3 (or 17) 3-HSD, is bacterial in origin.
Pseudomonas testosteroni can be grown with testosterone as the only source 
of carbon, and Dorfman & Ungar (1965) have indicated that the enzyme is 
somewhat non-specific. It has been shown to catalyse the oxidation of 
33-, 163- and 173-hydroxysteroids including ring A- aromatic compounds 
containing a 173-hydroxyl group (Talalay & Marcus, 1956).
C. 60c- and 68-Hydroxysteroid Dehydrogenases.
These enzymes have been reported in the urine of humans (Breuer & 
Breuer, 1965). However, little work has been done on these enzymes and 
their existence has largely been inferred from naturally occurring steroids 
and reaction products.
D. 7°-— and 7B-Hydroxysteroid Dehydrogenases.
There has been little work done with these enzymes also and their 
presence can only be inferred from naturally occurring steroids 
(Dr. J. Campbell, Glasgow Royal Infirmary, personal communication).
E. 11B-Hydroxysteroid Dehydrogenase.
A fuller report on this enzyme, which is the main subject of this 
thesis, is given on p. 1-4.
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F. 16oc- and 16R-Hydroxysteroid Dehydrogenases.
These enzymes have been poorly documented biochemically, Histo- 
chemically, NAD is the usual cofactor in human testis; adrenal, ovarian 
and placental 16 3-HSD will also use NADP, and an aromatic A-ring con­
figuration is less well utilised than a A^A-ring configuration (Baillie 
et al., 1966b).
G. 1 7 and 17B-Hydroxysteroid Dehydrogenases.
Corral - Gallerdo et al. (1966) have found a 17“-HSD in ovarian 
hilus cell tumour. Dorfman & Ungar (1965) have noted the presence of the 
enzyme in cow blood by the conversion of oestroneto 17“-oestradiol.
However, the literature on 17“-HSD1s is very sparse compared to 
173-HSD1s. Endahl & Kochakian (1962) using guinea pig liver and kidney 
found two 173-HSD*s, one requiring NADP present in the soluble fraction and 
the other requiring NAD in the mitochondrial fraction. Their enzymes 
were specific for C-^ neutral steroids, i.e. steroids without an aromatic 
ring A. Recently, Mulder et al. (1971) isolated and characterised the 
173-HSD from human erythrocytes.
A placental 173-hydroxysteroid dehydrogenase has been studied bio­
chemically (Langer et al., 1959; Adams et al., 1962; Jarabak et al.,
1962, 1963) which is dependent on oestrogens. NAD or NADP can both react 
as cofactors. Talalay (1957)* Crist & Warren (1966) and Williams - Ashman 
(1965) have discussed the implications of transhydrogenase action with this 
enzyme although this property has been vigorously disputed by Villee et al. 
(i960). Recently, Bums et al. (1971) have purified the human placental 
enzyme to a high degree of purity giving a single band by sodium dodecyl 
sulphate - polyacrylamide gel electrophoresis, corresponding to a 
molecular weight of approximately 33*500 daltons. Alanine was the only 
amino acid detected by N-terminal analysis and ultracentrifugation gave a 
molecular weight of 67*700 daltons which suggests that the enzyme exists 
in solution as a dimer.
Histochemically, 173-HSD has been found in a vide variety of tissues 
(Baillie et al., 1966b).
H. 20“- and 203-Hydroxysteroid Dehydrogenases.
Hubener et al. (1956) found a rat liver supernatant from a 17,500g 
centrifugate contained both 20“- and 203-HSD*s. Dorfman & Ungar (I965) 
have noted that these enzymes also occur in muscle, liver and kidney. 
Schoen & Samuels (1965) found a 20“-HSD in the testes of rat treated with 
ACTH. NADP is considered to be the biochemical cofactor for the 20“-HSD, 
although the histochemical system appears to be NAD dependent for the 
203-HSD (Baillie et al., 1966b).
203-HSD has been crystallised from Streptomyces hydrogenans (Hubener 
et al., 1959). It required NADH^ specifically and did not require NADPH^. 
Ganguly & Warren (1971) studied 203-HSD affinity labelling by cortisone 
21-iodoacetate with a view to characterising the binding site of 203-HSD, 
and a histidine residue was seen to react at that site.
I* 21-Hydroxysteroid Dehydrogenase.
Monder & White (1961) demonstrated that the 21-aldehydes of cortisone, 
cortisol and corticosterone were reduced to the corresponding alcohol 
function in rat and beef liver tissue.
3. Hormones in Salivary Glands.
Since the discovery by Lacassagne (1940) that there is sexual 
dimorphism in the murine salivary gland, it appears well established that 
steroid hormones influence salivary gland morphology and metabolism.
The work, however, has been carried out mainly with the androgens.
Not only submandibular gland size (Lacassagne, 1941; Zebrowski, 1972) 
but submandibular gland sialoglycoprotein concentration (Zebrowski, 1972) 
and protease (Sreebny & Meyer, 1964) activity have been shown to be 
androgen sensitive.
The implication of female sex hormones in the regulation of rat 
submandibular gland metabolism is, however, less clearly understood.
Liu (1968) on the effect of steroid contraceptives, Liu et al. (1969) 
on the effect of oestrogen, and Liu & Lin (I969) on the effect of pro­
gesterone have outlined the implication of female sex hormones on the 
structural growth and development of the submandibular gland of female rats.
Shannon and coworkers (1959* 1964* 1967* 1969a, 1969b) have investigated 
the presence of adrenocorticosteroids in human saliva, and they concluded 
that measurements of cortisol and cortisone found therein possess the 
potential of monitoring adrenocortical responses.
4. Aims of the Work.
It has only been in recent years that the presence of the enzyme, 
113-HSD, was discovered in salivary gland. Katz & Shannon (1964) 
incubated radioactive cortisol with dog parotid gland slices and found it 
to be converted to cortisone. Ferguson (1967) has demonstrated the 
histochemical localisation of 113-HSD in salivary gland duct cells.
Ferguson et al. (1970) reported that rat submandibular gland homogenates 
converted radioactive cortisol to cortisone in large quantities.
This present work has set out to report more fully on the investigation 
of 113-HSD in salivary gland with the purpose of verifying the previous 
physiological and histochemical reports.
The aims of the work are tabulated as follows:
A. (1) Provision of reliable and sensitive 113-hydroxysteroid 
dehydrogenase assay system for the male rat submandibular salivary gland 
(SMSG) involving the isolation and positive identification of the product 
(cortisone). Examination of the kinetic aspects of 11$-hydroxysteroid 
dehydrogenase activity in submandibular salivary gland homogenate with a 
view to providing optimal assay conditions. The parameters are:
a. duration of incubation
b. buffer
c. pH
d. cofactor concentration and preference
e. substrate concentration
f. temperature of incubation
g. tissue (homogenate) concentration
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(2) Investigation of other potential steroid substrates in 
submandibular gland.
(3) Identification of ll$-hydroxysteroid dehydrogenase in rat 
kidney and the comparison with the SMSG enzyme.
B. Separation of submandibular gland subcellular components and 
examination of 11$-hydroxysteroid dehydrogenase enzyme activity in each 
portion.
C. Histochemical examination of various enzymes including 11$-HSD
in the submandibular salivary gland in order to differentiate between acinar 
cell and duct cell function.
D. Tissue culture of salivary gland duct epithelium with the 
intention of studying 113-^ HSD present therein.
PART I
lip,-HYDROXYSTEROID DEHYDROGENASE ASSAY
- 13. - 
PART I
1.1 S-HYDROXYSTEROID DEHYDRO GENAS E ASSAY 
INTRODUCTION
1. Methods of Enzymic Analysis
There are two categories of method used to follow enzyme reactions,
i.e. continuous and sampling methods. Dixon & Webb (1964) and Bergmeyer 
(1963) have discussed the principles of enzymic analysis in detail, and 
Talalay (1962) reviewed enzymic analyses of hydroxysteroid dehydrogenases.
Continuous methods in the assay of dehydrogenases rely on coupling the 
enzyme reaction to another which involves the NAD- or NADP-oxidoreductase 
system. These are based on the extinction at 340nm of NADH and NADPH 
(Warburg & Christian, 1936) and the final amount estimated by using the 
molar extinction coefficient, 6.22x10 l/mole - cm. Hurlock & Talalay 
(1959)* Bush et a3.. (1968) and Koerner (1969) have assayed liver microsomes 
for 11$-HSD using this principle. This method is often preferred in the 
case of purified enzymes but in the case of using homogenates or tissue 
slices this is erroneous, although Schoer& Glick (1967) have determined 
3$-HSD in microgram samples of rat adrenal tissue and given a quantitative 
histological distribution of the fluorometric measurement of NAIS^ formed 
using an Aminco- Bowman Blank Subtract Spectrofluorometer. Bergmeyer
(1963) has, however, discussed the problems in the use of coupled enzyme 
assays. The histochemical staining technique for II3-HSD devised by 
Baillie et al. (1965c) uses a coupled enzyme system in which the dehydrogenase 
reaction is coupled with the reduction of the soluble and colourless 
tetrazoluira salt to the insoluble and coloured formazan which precipitates 
at the site of 11$-HSD activity (Fig. 1). However, it is not possible to 
have a reliable quantitation of 11$-HSD activity by histochemical studies.
In the sampling method of enzyme assays the reaction is stopped after 
a suitable time interval and then a measurement is made, either of the 
amount of product formed or of the substrate remaining. Koerner & Heilman
Figure 1. Principal of histocheiriical identification of U p-HSD.
Cortisol NAD Fonnazan
11$-IISD Diaphorase 
\
Cortisone NADH, Tetrazolium Salt
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(1964) used a method for the radiochemical analysis of 113-HSD. However, 
they used a substrate concentration of 1.4xlO”"^ M which is an unphysiological 
level of cortisol: Symington (1969) has suggested that in steroid studies
one should stay as near as possible to physiological conditions. For this 
reason the need for a reliable and sensitive method for the assay of 118-HSD 
in submandibular homogenates is required.
The assay used in this report makes use of a reverse radioisotope 
dilution assay, where a tracer amount of steroid substrate is used but 
carrier steroid is added at the end of the incubation and before extraction 
of the media. This allows the amount of radioactivity incorporated into 
each isolated product to be assessed accurately.
2. Radioisotopes.
A. Definitions.
(1) Radioisotopes: Isotopes which are radioactive, i.e. undergo 
spontaneous disintegration or transformation with emission of radiation.
(2) Isotopes: Nuclides of an element, characterised by having
the same atomic number but different mass numbers. j
There are different types of radiation:
a. (cc) Alpha radiation is emitted only by certain radioactive 
isotopes of the heavier elements. It consists of particles 
comprising two protons and two neutrons, i.e. a helium nucleus.
It has very limited penetrating power, example - radium 226.
b. (8) Beta radiation consists of high speed electrons emitted ,
I
from the nuclei of disintegrating atoms. Most 8 particles are 1
negatively charged (8 ), these being electrons, but some may be
■4* . I
positively charged (8 ), these being positrons. The penetrating i
power of beta radiation is low, examples - carbon-14, tritium,
phosphorous-32.
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c. ill. Gamma radiation occurs when the product nucleus is formed 
in an excited state. It has high penetrating power and is 
electromagnetic, similar to X-rays.
d. X-radiation results from electron capture and internal 
conversion. It is identical with Y radiation of the same energy.
B. Types of Counter.
(1) Geiger - Muller Counter (or G-M tube).
This consists of a large round outer electrode with a fine 
wire stretched along the centre axis of the cylinder and this wire 
is maintained at a high potential with respect to the outer electrode.
The inner space of the tube is usually filled with argon or an organic 
quenching compound such as ethanol. The open end of the tube is 
covered with an extremely thin window of mica beneath which is placed 
the radioactive material. ' When a charged particle enters the tube it 
causes the neutral counting gas to ionise, releasing electrons.
These free electrons are then accelerated to the positively 
charged central wire. As they progress through the gas additional 
molecules are ionised, with the result that a brief current surge is 
measured by a suitable electronic device and registered as one count.
If the multiplication of the electrons is limited, the size of the 
pulse is proportional to the energy of the absorbed radiation. A 
chamber operated in this voltage range is known as a gas proportional 
counter.
The multiplication process reaches saturation when the 
voltage is further raised and the size of the resulting electrical ^
pulse is independent of the energy of incident radiation. This region 
is known as the Geiger region of operation and it is in this voltage
»
region that the G-M tube works. This has the advantage that the count
i
rate is relatively independent of applied voltage and therefore the I
voltage supply does not have to be highly stable.
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There are several disadvantages of using G-M tubes or 
proportional counters:
a. Self-absorption:- Weak radiation (^H, ^C) is absorbed by
the mass of its own source and inefficient counting will occur.
b. Geometry:- Poor spreading of samples on the sample holdings 
can lead to errors.
c. Coincidence Correction:- When the disintegrations per 
minute are so high the counter cannot register all the electrical 
surges, counts lower than the actual events will be recorded. 
Correction factors may be introduced.
d. Background:- Background count represents ionisation caused 
by either cosmic rays or radioactive contamination of the counting 
chamber striking the G-M tube.
For monitoring radioactive chromatograms a chart recorder is attached 
to the rate-meter, the peaks on the chart relating to the zones of 
activity.
(2) Scintillation Counters.
These are extremely effective counting systems since problems 
of geometry, coincidence, and self absorption can be avoided. It 
consists of the principle that when ionising radiation is absorbed by 
a suitable phosphor there is an emission of light, and the scintillations 
are counted by very sensitive photomultiplier tubes. The light 
falling on a photocathode inside the glass envelope causes the emission 
of one or more photoelectrons which undergo several stages of internal 
amplication so that a pulse emerges at the anode which can be recorded 
with a scaler or rate-meter. The size of the pulse emerging from the 
photomultiplier tube is proportional to the energy of the absorbed 
radiation.
a. Solid Scintillation Counters:- These are used for y 
radiation detection. The light emitting substance is a thallium 
activated crystal of sodium iodide which is external to the sample. 
The advantages of the solid scintillation counter are:-
(i) Economy.
(ii) Large volumes of solution can be counted. Urine activity 
can be counted in a well crystal scintillation counter 
(cylindrical crystal with hole cut in one end for the 
sample to be inserted in) (Hallberg & Veall, 1962) or an 
annular cup crystal scintillation counter (the sample in 
this case surrounds the crystal) (Bell, I965).
(iii) Where the sample has to be left unchanged, this can be done 
by solid scintillation counters. Scintillation coffins 
have been constructed for in vivo counting of human beings 
and animals (Veall& Vetter, 1958).
b. Liquid Scintillation Counters:- A more detailed study of 
liquid scintillation counting theory is found in Bell & Hayes 
(1958) and Birks (1964). Liquid scintillation counting has 
considerable advantages over other forms of counting for isotopes 
such as carbon-14 and tritium which produce very weak beta rays.
(i) The sample is contained in the detection medium removing 
problems of proximity and geometry.
(ii) The exact efficiency of the samples can be determined.
(iii) One can differentiate between the radiation produced by 
two isotopes in the same sample.
In this process the energy passes first to the solvent (1, 4- 
Dioxane used in the present study) and then to the molecules of 
the primary fluor (PPO, i.e. 2, 5-Diphenyloxazole) which emits 
light at a wavelength of 363nm. This is not a suitable frequency 
for measurement and therefore a spectrum shifter or secondary
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fluor is added to the vial (POPOP, i.e. 1, 4-Bis- (5-phenyloxazol- 
2-yl) benzene) which re-emits the light at a longer wavelength 
(430nni)• These solvents and solutes have been reviewed by Turner 
(1967).
The liquid scintillation counters have the ability to 
discriminate between pulses of different energy. Sophisticated 
counters possess pulse height analysers with discriminators which 
may be set between energy limits so that undesired pulses can be 
eliminated, e.g. low energy background pulses.
There are certain sources of error which occur in the method,
e.g.:-
(i) Inhomogeneity.
(ii) Chemical and colour quenching.
(iii) Insolubilisation of materials in organic solvents such as 
toluene and dioxane.
Steroids which are non polar may be readily dissolved in almost 
any of the available liquid scintillation mixtures. However, 
many biological molecules are polar and will not dissolve in 
normal scintillation solvents. There are several methods which 
allow one to count these molecules. They include
(i) Decolourisation of biological samples by bleaching agents 
for counting in solution.
(ii) Solubilisation methods by acid and alkali.
(iii) Combustion and oxidation procedures for biological materials,
(iv) Carbon-14 dioxide and Sulphur-35 dioxide absorption into 
a variety of bases.
(v) Emulsion counting in Toluene/Triton x-100 liquid scintillant. 
(vi) Suspension counting - using Cab-O-Sil Gel.
(vii) Immersion counting - using filter paper.
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Aqueous solutions of ^-emitters of energy greater than 0.26 
MeV will emit light in the spectral region 300nm to 700nm which can 
be detected in the liquid scintillation medium. This type of 
radiation is called Cerenkov Radiation, subject to colour quenching 
but not to polar or dilution quenching (Belchner, 1953)*
C. Determination of Counting Efficiency.
The efficiency of counting of a sample is the ratio of the number 
of disintegrations recorded to those actually occurring in it, expressed 
as a percentage. The efficiency can be decreased by quenching, which is 
produced by processes that absorb some of the energy of radiation of 
the isotopes being counted. Examples of quenchers are polar substances 
such as water and ethanol or coloured samples which absorb light 
intended for the photocathode, i.e. around 430nm* Three main methods 
are used for determining counting efficiencies: internal standard,
channels ratio and external standard. Peng (1966) has reviewed 
methods of determining counting efficiencies.
(1) Internal Standardisation involves the addition of a known 
amount of radioactivity to the sample. The efficiency of the sample 
can be determined from the difference between the count rate before 
and after adding the internal standard.
(2) The Channels - Ratio Method depends on a shift in the overall 
spectrum of pulse heights produced by the quenching agent. The count 
rate in each of two channels is recorded. One selects a channel with 
the whole of the energy spectrum generated by the isotope in question 
and the other channel has a portion of this spectrum. There are 
changes in these channel ratios with quenching. A calibration curve 
relating the concentration of quencher to the ratio of counts in the 
two channels is drawn up.
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(3) External Standardisation involves the use of a gamma radiation 
source which generates a spectrum of Compton electrons in the sample 
vial. In the Nuclear Chicago liquid scintillation counter the gamma 
source is radioactive Barium and this spectrum is affected by quenching 
in the same way as the 3 particles in the sample. The count rate is 
automatically recorded in two of the channels at a given time and 
expressed as a ratio. A calibration graph of the ratio to the amount 
of quenching present is prepared.
D. The Principle of Isotope Dilution (Gorusch, 1966).
When a pure labelled compound is added to e.g. a biological 
fluid, it mixes with and becomes indistinguishable from the endogenous 
compound already present. If a sample of this compound is isolated in 
pure form the specific activity may be measured, and knowing the 
specific activity of and weight of the added material, it is now 
possible to calculate, regardless of the final yield, the amount of 
unlabelled compound already present in the mixture. In reverse 
dilution analysis, e.g. during in vitro study of the metabolism of 
labelled compounds by biological tissue, known amounts of unlabelled 
•carrier* metabolites being studied are added at the end of the 
incubation period and then isolated in a radiochemically pure form.
Again, from their specific activity the original amounts of labelled 
metabolites can be calculated, regardless of losses during extraction 
and purification, e.g.:-
Let Y dpm/mole = final specific activity of purified
metabolite
G mole = amount of unlabelled *carrier1 metabolite
added
X dpm “ original amount of radioactivity of
labelled precursor added
then percentage conversion to metabolite 
= x 100
assuming the labelled precursor to have negligible mass compared with 
the metabolite.
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3. Tissue Homogenates.
A higher degree of fragmentation than tissue slicing or mincing is 
homogenisation. A homogenate is a whole tissue preparation in which the 
cell disruption is as complete as possible, while at the same time the cell 
particulates remain intact. For reviews of tissue homogenisation see 
Potter (1955? 1964).
One of the earliest homogenisers was that designed by Potter &
Elvehjem (1936) which is a test tube with a close fitting glass pestle, 
the end of which has teeth. The tissue with some liquid medium is placed 
in the tube and the pestle, which is driven by an electric motor, is slowly 
moved up and down inside the tube. The tissue is macerated by the teeth 
and finely ground as it passes the pestle. There are pestles made of 
plastic such as Teflon, often in conjunction with a stainless steel shaft, 
which can withstand more rugged conditions.
Homogenates are also produced by machines that use high speed cutting 
knives:
(1) Waring Blendor: In this type of machine the blade assembly
is fixed into the bottom of the vessel and driven from underneath. This 
device can deal with volumes of 25ml to 500ml. The vessels are of glass 
or stainless steel.
(2) Virtis Homogeniser: In this type of machine the blades are
introduced through the top of the vessel. It can handle small volumes of 
homogenate.
(3) Colloid Mill: This device is more efficient than the Waring 
Blendor with regard to cell breakage, it can be efficiently cooled and it can 
rapidly process large quantities of material.
(4) Ultra-Turrax Homogeniser: In this device the blades cut up small
quantities of tissue but there is a danger of too high a degree of 
fragmentation.
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4. Principles of Isolation and Identification of Steroids.
A. History.
Since the first steroid hormone, oestrone, was isolated in 1929 there 
have been many advances in techniques for isolation and identification of 
steroids. There was much work done on steroid metabolism in the 1930’s 
with the classical technique of administering large doses of known 
crystalline steroids to experimental animals and isolating crystalline 
metabolites from body fluids. Girard & Sandulesco (1936) discovered two 
reagents known as Girard’s reagents T and P, (trimethylaminoacetohydrazide 
hydrochloride and pyridylacetohydrazide hydrochloride) which could efficiently 
separate oxo form steroids from non-oxo form steroids. Reichstein (1936) 
introduced the use of absorption column chromatography for the separation 
of adrenocortical steroids, and chromatographic techniques advanced from 
there. Paper chromatography (Zaffaroni et al., 1950) introduced steroid 
analysis at the microgram level. Partition column chromatography (Martin & 
Synge, 1941), thin layer chromatography (Kirchner et al., 1951)> gas 
chromatography (Eglington et al., 1959), and gel chromatography (Sjovall 
et al., 1968) are other chromatographic techniques developed for the 
isolation and identification of steroids.
Countercurrent distribution, pioneered by Engel et al. (1950) with 
oestrogens, has now been brought to a high level of efficiency for most 
steroids.
For the spectral identification of steroids there are many techniques 
available:
Infrared Spectroscopy (Furchgott et al., 1946);
U.V. Determinations (Dorfman, 1953);
Optical Rotary Dispersion (Djerassi, 1957);
Nuclear Magnetic Resonance (Shoolery & Rogers, 1958);
Mass Spectrometry (Reed, 1958);
X-ray Crystallography (Bernal, 1932).
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There are also certain colour reactions which aid analytical 
determination of steroids: Kober reaction (Kober, 1938), Zimmermann reaction
(Zimmermann, 1935) and fluorescense analysis (Cohen & Bates, 1947).
Isotope methods also have helped the isolation and identification of 
certain steroids.
B. Chromatography (used for isolation and identification). 
Chromatography represents one of the greatest technical advances in 
biochemistry of the past several years. In its many methods it has 
revolutionised the separation and detection of steroid mixtures as well as 
the determination and identification of isolated steroids.
There are several kinds of chromatography:
(1) Adsorption Chromatography.
This involves separation of the steroid mixture between solid 
and liquid phases. There are two forces:-
a. Adsorption which tends to hold the solute to the surface 
of the adsorbent.
b. Elution which tends to remove the solute from the adsorbent.
A highly polar substance is that which exhibits more affinity for the 
adsorbent and a low-polar substance is that which exhibits more affinity 
for the fluid phase.
(2) Partition Chromatography.
This involves separation of the steroid mixture between 
two liquid phases or a gas - liquid phase according to the relative 
affinity between the solute and each of the two phases of the system. 
Under partition chromatography are the techniques of:-
a. Paper chromatography
b. G.L.C. (gas liquid chromatography)
(3) Thin Layer Chromatography (T.L.C.).
Thin layer chromatography has developed from column 
adsorption chromatography. It is performed on open layers of
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adsorbent materials supported on glass plates. A thin uniform film 
of silica gel or aluminium oxide containing a binding medium, such as 
calcium sulphate, is spread on to a glass plate, the thin layer allowed 
to dry and then activated by heat at 110°-250°C. The steroid 
dissolved in solvent is spotted on to the plate and once the solvent 
has evaporated the plates are placed vertically in a glass tank which 
contains a suitable solvent, and in a short time, e.g. 30-60 minutes, 
a separation is produced by the solvent rising through the thin layer, 
differentially carrying the components of the spots from the origin 
depending on the adsorption of the components on the thin layer. The 
spots may be detected by a variety of reagents or dyes. Camag DSF - 5 
silica gel with an added ultraviolet indicator shows corticosteroids 
absorbing under U.V. light. Thin layer chromatography has 
advantages in that it is speedy, efficient, sensitive and drastic 
detection agents can be used.
Neher (1964) reviewed thin layer chromatography. In the 
review he deals in detail with preparation of adsorbent, of the layer 
application of the specimen, the choice of suitable solvents and of 
detection agents.
(4) Paper Chromatography.
Developed in 1944 (Consden et al., 1944), it was not adopted 
for steroid separations until the introduction of special solvent 
systems by Zaffaroni et al. (1950) and Bush (1952). Several reviews 
have been written on paper chromatography (Bush, 1961; Neher 1963, 
1964; Dominguez, 1967). Separation of steroids on paper is based on 
a liquid partition of the compounds. The steroid mixture is applied 
to a strip of filter paper (the support) on which is the stationary 
water phase. The steroid mixture is transported in a given direction 
by a suitable solvent system; it will travel along the paper at a 
certain fraction of the rate of travel of the solvent front, the
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fraction depending on the distribution of the compounds between the 
two phases (stationary and mobile). The ratio of the distance 
travelled by the compounds to the distance travelled by the solvent 
front from the original spot is called the Rf value of the compound. 
Under strictly controlled conditions the Rf is an important constant 
for identification purposes.
Paper chromatography has several disadvantages in that it 
is slow and drastic detection agents cannot be used.
(5) Gas Chromatography.
Gas chromatography was postulated in 1941 and introduced 
into practice in 1952 by James & Martin. However, the first report 
of its successful application to the field of steroids did not appear 
until 1959 (Eglington et al., 1959).
There have been several reviews on the gas liquid chroma­
tography (G.L.C.) of steroids (Neher, 1964; Wotiz & Clark, 1966; 
Brooks & Sabkiewicz, 1967; Horning et al., 1969). To enable 
identification of the structure of unknown compounds, G.L.C. has been 
standardised resulting in the Retention Index system of Kovats (1965). 
Menini & Norymberski (1965) introduced a method not only to separate 
steroids but also to quantitate them providing an internal standard is 
used. An ancillary technique used in direct conjunction with G.L.C. 
is the monitoring of the column effluent by a mass spectrometer 
(Eneroth et al., I964). This gives excellent separation of compounds 
in a mixture and a reliable means of identification of each compound.
Gas chromatography has become the preferred method for 
rapidly and accurately analysing any volatile substance. It is a 
form of partition chromatography differing from the others in that the 
mobile phase is a gas and the stationary phase is a high boiling liquid 
with an inert solid as a support. A limitation of G.L.C. is that the 
components must be volatile. However, the method is now increasingly
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being extended to include non-volatile and polar compounds by the conversion 
of these into volatile derivatives. This separation method is very fast, 
sensitive and usually an effective means of separation. The effluent gas 
passes through a monitoring device which measures changes in the gas and 
converts these to electrical responses on a recorder. There are several 
advantages of G.L.C.
a. Only small amounts of complex mixture, e.g. lul, are needed 
for efficient separation.
b. Greater ease of detecting traces of solute in a gas phase 
compared with a liquid phase.
c. Separations are reproducible provided the conditions are 
the same.
Disadvantages are:-
a. Components must be volatile.
b. Components may be decomposed by high temperature, e.g.
the corticosteroids, cortisol and cortisone are degraded by
G.L.C.
c. Cost of equipment.
C. Spectral Examination for Identification of Steroids.
(1) Colour and Fluorescence Reactions.
These reactions frequently indicate the presence of certain 
functional groups in the molecule on the steroid, e.g. A^-3-oxo group, 
17-oxo group, phenolic nucleus etc. However, there are relatively 
few reactions suitable for the identification of individual steroids. 
There is a specific reaction for oestrogens, the Kober reaction 
which with sulphuric acid in the presence of phenol gives a yellow 
colour turning pink after dilution with water.
(2) U.V. Spectroscopy.
Engel (1963) has written a review on ultraviolet absorption, 
fluorescence spectra and absorption spectra in concentrated sulphuric
- 25 -
acid. These spectra can be easily measured but only provide useful 
information on functional groups, e.g. the A^-3-oxo group has a U,V, 
absorption at 24-Onm.
(3) Infra-Red Spectroscopy.
I.R. spectroscopy has the advantage that an I.R. spectrum 
is unique and characteristic for a compound by comparison of its 
spectrum with that of a reference sample. There is an atlas of 
steroid I.R. spectra (Neudart et al., 1965).
(4) Mass Spectroscopy.
This is perhaps the most sensitive method for the identi­
fication of micro-amounts of material. Spectra may be obtained with 
1-1Opg of a compound.
(5) X-Ray Crystallography.
This provides the most certain identity of a compound but it 
requires highly specialised equipment which is not readily available. 
There is also much time and labour involved in this technique. A 
survey of X-ray crystallography can be found in Parsons et al. (1956).
(6) Nuclear Magnetic Resonance.
This method is of great importance for the characterisation 
and localisation of substituents as well as for the configuration of 
individual rings. However, it does not normally reveal complete 
structure and has not been developed for microanalysis. Tables of 
spectra in a solution of deuterochlorofora (which least disturbs the 
absorption of the measured substance) for steroids have been shown by 
Shoolery & Rogers (1958).
(7) Optical Rotary Dispersion.
The optical rotation of an organic compound depends on the 
wavelength of light used. The estimation of difference in the optical 
rotation dependent on the wavelength of ultraviolet radiation in 
the region of 280-700nm is carried out. From the measured values a
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dispersion curve is constructed. This method is important especially 
for the localisation of oxo groups in the steroid molecule as well as 
for the configuration of rings (cis, trans) and was developed for 
steroids by Djerassi (1957? I960). However* the method is not useful in 
the identification of an unknown compound.
D. Identification of Isotopically Labelled Steroids.
There has been a review article written on the identification 
of steroids by Brooks et al. (1970) and in this there are described 
methods of identification of isotopically labelled steroids. Berliner & 
Salhanick (1956) described a method where the isolated steroid is 
converted to derivatives and the specific activity of the derivatives 
compared with the isolated steroid. Recrystallisations, where the 
specific activity of the residues from the mother liquors agree with 
that of the last crop of crystals (Axelrod et al., 1965)? also give 
positive identification and verification of purity of a steroid. The 
specific activities should agree within - 5% of the mean value.
1. llG-Hydroxysteroid Dehydrogenase Assay in Rat Submandibular Salivary
Gland.
A. Materials.
Cortisol-4-^C (Specific Activity, 52-58mC/mM) was purchased from 
the Radiochemical Centre, Amersham, Bucks and was purified by thin layer 
chromatography in the system of chloroform: ethanol (85:15v/v).
Reference steroids (cortisol, cortisone, cortisone acetate and 
adrcnosterone), nicotinamide adenine dinucleotide (NAD) and nicotinamide 
adenine dinucleotide phosphate (NADP) were purchased from the Sigma Chemical 
Company, London. The purity of the reference steroids was established by 
recrystallisation and thin layer chromatographic identification. Cortisol 
was recrystallised in methanol - water, cortisone in methanol - water, 
cortisone acetate in acetone - ether and adrenosterone in ether - ethanol. 
Their respective Rf values in the thin layer chromatography system of 
chloroform:ethanol (85:15v/v) were O.48, 0.60, 0.74* 0.80. All the water 
was glass redistilled. All solvents and other chemicals were of analytical 
grade and were obtained from the British Drug Houses Ltd., Poole, Dorset. 
Silica gel Camag DSF - 5 +  U.V. indicator was used for thin layer chroma­
tography. The buffers used were 0.05M tris - hydrochloride (pH7.0 - 9.0), 
0.067M Sorensen1s phosphate (pH5.3 - 8.0), 0.1M Clark & Lub*s borate 
(pH8.0 - 10.0) and tripotassium phosphate (pH7.5 - 11.0). Young adult 
male Sprague - Dawley rats were purchased from A. Tuck & Son Ltd., England 
and were in the range of 200-250g at the time of use. The scintillation 
fluid used for radioactive counting was NE 250, a dioxane-based scintillant 
purchased from Nuclear Enterprises, Sighthill, Edinburgh.
B. Washing of Glassware.
All glassware was cleaned by steeping in 2% RBS 25 (Chemical Con­
centrates Ltd., London, SW11 6RX) for 24 hours. This cleaned any residual
steroid or radioactivity from the glass surface. RBS 25 was preferred to
chromic acid because it is safer and easier to use. The cleaned glassware
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was rinsed three times in tap water and twice in glass distilled water.
The glassware was then put into a hot oven at 130°C to dry. After drying, 
the glassware was stored until further use.
C. Preparation of Homogenate and Incubation.
Mature Sprague - Dawley male rats (weight 250g), maintained on a 
commercial diet 41B, were killed by cervical dislocation and the sub­
mandibular salivary glands (Fig. 2) were dissected out, chilled, weighed and 
homogenised with a teflon homogeniser - lOOmg. tissue with 9.9ml of buffer. 
Cofactor (I3.8y moles of NAD or NADP) was added to the homogenate and the 
pH of the medium adjusted if necessary. The range of pH examined was 
pH5.0 - 11 but for optimal conditions of pH the NAD-linked II3-HSD was 
prepared for assay at pH8.5 and the NADP-linked.enzyme at pH7.6. The 
homogenate was then transferred to 50ml Erlenmeyer flasks containing 
cortisol-4-^C (0.3-30n moles) dissolved in 0.05ml propylene glycol.
A substrate concentration of lOn moles was used for the majority of the 
assays. The final volume of the assay was 11ml.
The flasks were incubated at 37°C in air in a shaking water bath 
for 0-64 minutes and the reaction was stopped by adding 2 volumes of 
acetone. To this mixture were added 1.7y moles of both carrier cortisol 
and carrier cortisone in order that the amount of radioactivity incorporated 
into either the substrate or product could be assessed accurately. Control 
flasks were prepared by boiling the homogenate for 30 mins. and incubating 
as above.
D. Extraction Procedure.
The flask contents were allowed to equilibrate for 1 hr. and then 
filtered with washings of acetone:water mixture (2:lv/v). From the 
filtrate, acetone was evaporated under vacuum and the steroids were 
recovered by extracting twice with 3 volumes of benzene:chloroform (6:lv/v) 
and once with 3 volumes of ethyl acetate. The total recovery of the added 
radioactivity was in the range of 87-95# (Table 1). The combined organic 
extracts were dried over anhydrous sodium sulphate and taken to dryness.
F±p;u_i'e_ ^2. Diagram of male rat salivary glands a nd adjacent 
stmcturcs.
Lymph N odesSublingual
Gland
Ext r a - o r b i t a l  
Lacrimal G land
Submandibular  
Gland " Parotid  G land
I
CPM in Sample CPM after Extraction % Recovery
591,965 516,800 87.3
591,965 562,080 94.9
591,965 561,440 94.8
591,965 519,520 87.7
591,965 524,640 88.6
Table 1. Recovery of in solvent phase after extraction
(Solvent Extraction
2 x 3  vols. Benzene:Chloroform (6:1 v/v)
+ 1 x 3  vols. Ethyl Acetate)
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E, Isolation and Identification of Radioactive Zones.
The metabolite (cortisone) was separated by chromatography on thin 
later plates coated with silica gel; the system was chloroform:ethanol 
(85:15v/v). Another three T.L.C. systems were examined and the Rf values 
found are shown in Table 2. Localisation of the steroids was obtained 
by using a U.V. light and a strip scanner (Nuclear Chicago) for the 
distribution of ^C-compounds. The two areas representing cortisol and 
cortisone were eluted separately with methanol.
The chromatographic mobilities of the two radioactive compounds were 
compared with those of reference steroids and found to correspond to 
cortisol (Rf O.48) and cortisone (Rf 0.60). For positive identification 
of the radioactive cortisone zone this was subjected to reverse isotope 
dilution with non-radioactive cortisone and the specific activity remained 
constant after repeated crystallisations (Table 3)» The acetate, prepared 
using acetic anhydride and pyridine (Bush, I96I), was found to have a 
constant specific activity. Oxidation of the radioactive cortisone zone 
and carrier cortisone by potassium chromate (Bush, 1961) both resulted in 
the formation of adrenosterone, as identified by chromatographic mobility 
of the reference adrenosterone (Rf 0.80).
F. Analytical Measurement.
Measurement of ^C-steroids was carried out in a Nuclear Chicago liquid 
scintillation counter with a 65-69$ efficiency. Quenching corrections 
were made by employing the external standard method but all counts recorded 
showed maximum efficiency and negligible quenching.
The mass of the steroids was quantitated in a Unicam S.P. 500 spectro­
photometer using the specific absorbances of the steroids, the blank being 
an equivalent methanolic elution from a silica gel plate run in the same 
T.L.C. system, and the calculation of percentage transfer of cortisol to 
cortisone was produced from the reverse isotope dilution formula:-
System Adsorbent Rf of Cortisol Rf of Cortisone
Benzene:Methanol 9si v/v Silica Gel 0.16 0.20
Chloroform:Ethanol 95 25 v/v Silica Gel 0.10 0.22
■^Chloroform:Ethanol 85:15 v/v Silica Gel 0.48 *0.60 .
Chloroform:Acetone 8:2 v/v Silica Gel 0.12 0.23
* Preferred System
Table 2. Thin layer chromatography systems for the separation 
of cortisol and cortisone.
Steroids
Spec'll
(clpn
ic Activity j 
i/u mole)
Crystals Mother Liquor
Cortisone
(from Methanol-Water) 1st 1006 1089
2nd 1001 1045
3rd 996 1017
Cortisone Acetate 1st 1113 1070
(from Acetone-Ether)
2nd 1100 1058
3rd 1058 1113
Table 3.
Recrystallisation to constant specific activity with 
authentic steroids of the metabolite, cortisone, and 
the metabolic derivative, cortisone acetate.
30 -
Specific activity of recovered cortisone
% Conversion =
Total counts put originally
(in the form of cortisol)
The labelled precursor (cortisol) was assumed to have negligible mass
compared with the carrier.
The decrease in the percentage of the substrate could also be used as 
a measurement.
G. Units of 11B-HSD Activity.
One unit of llg-HSD activity is defined as In mole of cortisol 
converted to cortisone per minute.
H. Spectrophotometric and Fluorometric Methods of llft-HSD Analysis.
The activities are determined optically from the rate of reduction of
NAD in the presence of the appropriate steroid.
The spectrophotometric reaction mixture contained in a final volume 
of 3ml:100y moles of phosphate buffer pH9.7> 0.4h moles of NAD, lOOpg 
(275n moles) of cortisol dissolved in methanol and lOOmg. of submandibular 
salivary gland in a 10$ (w/v) homogenate in 0.25M Sucrose (B.D.H., Dorset). 
The increase in absorbance at 340nm and room temperature (20°C) was measured 
in cuvettes of 1.0cm. light path against a blank containing all the 
ingredients except the steroid.
The fluorometric assay was based on the method of Schoer & Glick 
(1967) who used an Aminco-Bowman Blank Subtract Spectrophotofluorometer 
for the analysis of 3g-HSD in rat adrenal. To alter the method for 
submandibular 113-HSD assay, cortisol was used as substrate and homogenate 
was used in place of microtome sections. The reaction mixture contained 
lOpl of a 1% (w/v) submandibular salivary gland homogenate prepared in
0.15MKC1, 50yl of NAD - buffer mixture (20 volumes of 0.1M glycine buffer 
at pH9.6, 10 volumes of 0.76mM NAD and 20 volumes of distilled water - 
prepared fresh for use). The fluorescence (345nm excitation, 455nm 
fluorescence) of this was recorded at room temperature (20°C). To the 
mixture was added lpl of 2mM cortisol in ethanol and the fluorescence was
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read each minute at room temperature. A standard curve of concentration
/L
of NADH^solutions measured fluorometrically over the range 4.3x10” M to 
3.1x10 was plotted. The blanks used were a substrate blank, an enzyme 
differentiation blank where ethanol was added without steroid to see if 
there was alcohol dehydrogenase activity, and an enzyme blank.
Note: All blanks did not show any activity, and for the enzyme determi­
nations the blank subtract apparatus was used to block out the particulate 
matter with a substrate blank.
2. Gas Liquid Chromatography for the Identification of Borate Buffer 
Products.
The steroid products were prepared for on-gauze gas liquid chroma­
tography by the method of Menini & Norymberski (1965). Stainless steel 
Dixon gauzes were used and the steroids were separated using a Pye Gas 
Chromatograph (Model 64) equipped with hydrogen flame ionisation detectors 
and column composed of 1.4$ 0V-17 (Applied Science Laboratories, Pennsylvania).
The column temperature was 230°C and the nitrogen flow was 50ml/min.
The incubation products were identified by comparison of their retention 
times with those of authentic compounds.
3* Incubations of Submandibular Salivary Gland with Cortisone and 
Corticosterone.
A. Cortisone.
Submandibular salivary gland homogenates were prepared and incubated 
as described on p. 27, replacing the steroid substrate with 8n moles of
p moles) or NADP^
(I4y moles). Cortisone-4-^C (S.A. 57mC/mM) was purchased from the 
Radiochemical Centre, Amersham and the radiochemical purity ascertained in 
the system chloroform:ethanol (85:15v/v). Incubations were carried out 
at pH7.4 for 10, 20 and 30 mins. duration, and incubations of 7 mins. 
duration at pH values 7.4, 8.0 and 8.5 were also investigated. Control 
flasks containing homogenate that had been boiled for 30 mins. were also 
incubated. Carrier steroids of 1.7y moles cortisone and 1.7p moles
cortisone-4- C and the cofactor with either NADIL (14
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cortisol were added at the end of the incubations and the steroids extracted 
and separated.
B. Corticosterone.
Corticosterone-4-^C (S.A. 6lmC/mM) was purchased from the Radio­
chemical Centre, Amersham and 8n mole aliquots were incubated at pH8.0 
with submandibular gland homogenate according to the assay on p.27»
Both cofactors, NAB and NABP, were used for the incubations which lasted 
30 mins. Non-radioactive corticosterone and 11-dehydrocorticosterone were 
run in the T.L.C. systems, chloroform:ethanol (7:3v/v), chloroform:acetone 
(8:2v/v), and cyclohexane: ethyl acetate (l:lv/v) in order to find the best 
system for separation. The chloroform:acetone (8:2v/v) system gave the 
best separation with Rf values for corticosterone and 11-dehydrocorti­
costerone of 0.24 and 0.33 respectively. The radioactive metabolites 
extracted from the above incubations were separated in this system.
4* llft-HSB in Rat Kidney.
Adult male Sprague - Bawley rats (200-250g) were killed by cervical 
dislocation and from these, kidneys were excised, blotted and weighed.
Kidney homogenate was prepared by 6 strokes at l,000rpm with a teflon 
homogeniser in isotonic saline at a concentration of 1C$ (w/v).
In the assay for the enzyme lOn moles of cortisol-4-^C or 
cortisone-4-^C was used as substrate dissolved in 0.05ml propylene glycol. 
lOOmg. wet weight gland equivalents of 10^ (w/v) homogenate (i.e. 1ml), 
8.95ml of 0.067M phosphate buffer and 1ml of cofactor mixture were 
combined to a final volume of 11ml. NAB (I3.8y moles) or NABP (l3.8p 
moles) was used for the cortisol incubation at pH value of pH8.5 and 
pH7.4 respectively. When cortisone was used as substrate 13.8y moles 
of both reduced pyridine nucleotides were used at pH7.4» The remaining 
conditions of assay were as described by the reverse isotope dilution 
assay on p.27*
r
J|
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RESULTS
1. llfi-HSB Assay with and without Carrier Steroids.
When no carrier steroids were used in the assay there was a difficulty
in determining the specific activity of the separated material as when the
amount of steroid recovered falls to a few micrograms the accuracy of the
determination of llg-HSB activity falls off sharply.
The addition of carrier steroids to make the method a reverse isotope
dilution analysis was found to be a far better method of assay. The U.V.
absorbing spots could be easily detected under U.V. light. Carrier
steroids allow the specific activities of the isolated products to be
measured accurately and the boiled homogenate incubations were in the range 
4*of 2.48 -  1% conversion. This method proved reliable, sensitive and 
accurate•
2. llp-HSD Assay by Spectrophotometric and Fluorometric Methods. 
Spectrophotometric and fluorometric analyses were useless for the
detection of 11$-HSB in submandibular salivary gland homogenate. There
was no activity seen in the homogenate preparations using either of the
two methods.
They were not sensitive enough assay methods for the detection of 
113-HSB in submandibular salivary gland.
3. Effect of Various Parameters on lift-HSD Activity in SMSG Homogenate. 
The 113-HSD assay (p.27) was used, the parameters of activity being
altered where shown.
A. Time of Incubation.
Figs. 3 and 4 show the progress curves of the II3-HSB reactions using
NAB and NABP as cofactors. The curves are in the general form of enzyme
velocity reactions. The initial velocity is increasingly proportional; 
up to 3 minutes for the NAB-linked 113—HSB at pH8.3> up to 9 minutes at 
pH7.3 and up to 25 minutes for the NABP-linked enzyme at pH7.3> and after
these times the velocity falls with time. It can be seen that the
Figure 3« Effect of time of incobr.tion on NAD-linked
llft-HSD activity in snbmejicjibriJar gland homo^cnatc.
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initial velocity is (approx. 1.0 unit) greater at pH8.3 for the NAD-linked 
113-HSD and therefore this pH must be nearer the optimum than pH7.3»
Therefore an appropriate time of incubation for the initial rate of 
reaction of NAD-linked 113-HSD to be proportional would be 2 minutes.
An appropriate time of incubation for the initial rate of reaction of the 
NADP-linked 113-HSD-would be 7 minutes.
B. pH and Various Buffers.
Using borate buffer (pH8 - 10) a chemical oxidation of both cortisol 
and cortisone occurred. There was a radioactive area of lower polarity 
(over Rf 0.70) when an incubation was carried out. Analysis of this area 
by gas liquid chromatography showed that ll$-hydroxyandrostenedione and 
-adrenosterone had been formed. Cholesterol was also present in this area. 
The cortisol was probably oxidised to the 113-hydroxyandrostenedione and 
the cortisone oxidised to the adrenosterone. Gas liquid chromatography 
can degrade cortisol and cortisone to these products but since the less 
polar area was used for G.L.C. determination then this factor can be 
discounted.
A similar problem arose using tris-hydrochloride buffer (pH7 - 9) 
where a chemical reaction between the steroids and the buffer took place.
When cortisone was incubated with tris-hydrochloride buffer alone for 
2 hrs. a radioactive peak of Rf 0.35 was formed, and when cortisol was 
incubated a peak of Rf 0.25 was formed.
No chemical reaction occurred between the phosphate buffers (pH5.3 - H )  
and the steroids. The phosphate buffers were therefore considered 
suitable for the 113-HSD assay and neither of the other buffers was con­
sidered of use.
pH curves of the NAD-and NADP-linked 113-HSD1s were established by 
incubating cortisol at different pH values. Care had to be taken to 
measure the pH of incubation mixture before and after incubation as it can 
alter significantly. The pH curves are shown in Fig. 5 and these show
Figure 5» Effect of pH on llf-’-HSD activity in 
submaud i.bular gland homogeuate.
NAD
NADP
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that the optimal pH of the NAD-linked II3-HSD is between pH8.1 and pH8.9 
and the optimal pH for the NADP-linked II3-HSD is pH7.6.
C. Cofactor Concentration.
Differing cofactor concentrations of NAD and NADP were incubated in 
113-HSD assays and the results are graphed of enzyme activity against 
cofactor concentration in Fig. 6. pH8.5 was used for the NAD incubations
and pH7.6 for the NADP incubations.
It is seen from the curves that 13.8y moles (l.26mM) of cofactor is 
a sufficient amount to add to the assay system in order not to become a 
limiting factor in the reaction.
The substrate concentration for the assays was 0.6yM and the saturating 
amount of cofactor needed was 1.26mM which is 2,000 times the substrate 
concentration which shows that the enzyme system is very crude.
When no cofactor was used in an incubation at pH7.4 only a 2% conversion 
of cortisol to cortisone was observed which shows the need for pyridine 
nucleotide cofactors to give a large enough and, therefore, more reliable 
conversion.
D. Temperature.
113-HSD assays were carried out for the NAD- and NADP-linked 113-HSD's, 
varying the temperature of assay. Graphs were drawn of these parameters 
against enzyme activity and are shown in Fig. 7» The optimal temperature 
of the enzyme in the presence of both cofactors is 37°C: however, the
importance taken from this result is discussed on p.39»
E. Substrate Concentration.
With other variables (e.g. pH, temperature, cofactors) and the amount 
of enzyme being constant as for the 113-HSD assay conditions on p.27> the 
velocity of 113-HSD activity was measured with increasing concentrations of 
substrate.
A direct plot of velocity against substrate concentrations is of little 
value in determining a true Vmax, which is the maximal velocity of the
Figure 6 . E f f e c t  o f  c o f a c t o r  c o n c .c n t ra t  i on on 1 V;-HSD a c t i v i t y  
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reaction for the parameters given, and therefore a true Km or nMichaelis 
Constant" cannot be determined properly. The "Michaelis Constant" of an 
enzyme is numerically equal to the substrate concentration at which the 
velocity of the reaction (v) equals ^ of the maximal velocity (Vmax) or 
the substrate concentration which half saturates the enzyme. The Km is 
characteristic for an enzyme and substrate. Nevertheless true Km and 
Vmax values can be obtained by reciprocal plots of v and s (substrate 
concentration) according to Lineweaver & Burk (1934).
The results of the present investigation are shown in Figs. 8 and 9.
The straight lines were obtained by computing the data by linear regression
on the Olivetti Programma 101-.
The Km values for the NAD- and NADP-linked 113-HSD's were 0.48yM and
0.95PM respectively and the corresponding Vmax's were 1.27n moles/min. 
and 0.37n moles/min. respectively.
From the values given it seems that the cofactor preference of the 
submandibular 113-HSD is for NAD rather than NADP which seems to conflict 
with reports given by previous authors (see p. 2 ) for other tissues.
Very high substrate concentrations were found to be impracticable 
because a value of lOxKm inhibited the reaction.
F. Tissue ('Enzyme') Concentration.
Different aliquots of submandibular salivary gland were assayed for
NAD-linked 113-HSD activity and the result of the investigation is shown
in Fig. 10, a graph of enzyme activity versus ‘enzyme1 concentration.
The line drawn is a straight line demonstrating that enzyme activity is 
increasingly proportional to the 'enzyme1 concentration for the II3-HSD 
assay given (p.27).
There is no falling off from the linear relationship due to a limitation 
in the capacity of the method of estimation, e.g. insufficient substrate.
The result shows that two molecules of II3-HSD acting independently in 
solution will transform twice as much cortisol in a given time (2 mins.) j
Figure 8. Linoy/eaver-Burk plot of NAD-linked II3-H.SD 
in submandibular gland homogenate.
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than one molecule. This verifies the validity of the enzyme assay.
4. Metabolism of Steroid Substrates.
The effect of cortisone as substrate is shown in Table 4. There
was little metabolism of cortisone showing that the 11$-HSD of rat sub­
mandibular salivary gland is not fully reversible. The reduction of 
cortisone is small compared with the oxidation of cortisol.
Corticosterone showed a 30^ conversion to 11-dehydrocorticosterone 
(identification by Rf values) with both cofactors, NAD and NADP. An 
identical incubation with cortisol-4-^C and NAD showed a 76.5$ conversion 
to cortisone.
5. Metabolism of Cortisol and Cortisone in Rat Kidney Homogenate.
The results of this investigation are shown in Table 5« With cortisol 
as substrate, there is both NAD- and NADP-linked 11$-HSD activity. This 
appears to be of a level higher for the kidney NADP-linked 113-HSD
(O.84 units) than for the submandibular gland enzyme (0.37 units) but is
the same level of activity for the kidney and submandibular NAD-linked 
II3-HSD. It is not possible to say whether the oxidation of the 113-
hydroxy group of cortisol is equally effective with either NAD or NADP as
a different pH has been used for each assay.
With cortisone as substrate, there is very slight II3-HSD activity, 
the conversion to cortisol being small (0.09 units) and so the enzyme 
cannot be fully reversible. There is a large conversion to a more polar 
metabolite (Rf 0.40) and the possible explanation of this metabolite is 
discussed on p. 41 .
pH Incubation Time (mins.)
Cofactor
.. ........ . f
Yield of 
Cortisol (%)
7.4 10 n a d h2 4.8
7.4 20 n adh2 3.1
7.4 30 n a d h2 4.9
7.4 10 nadph2 7.1
7.4 20 n a dph2 5.7
7.4 30 NADPH2 6.3
7.4 7 NADH2 3.5
oGO 7 NADH2 2.8
8.5 7 NAHH2 2.2
7.4 7 NADPH2 3.4
00 • o 7 NADPH2 3.9
8.5 7 NAPPH2 3.4
Control incubations avera<?e 2 .5%
Table 4» The effect of time of incubation and pH on the 
reduction of cortisone to cortisol by rat submandibular 
salivary gland in vitro.
Substrate pH Cofactor No. of Experiments
11$-HSD activity 
(enzyme units)
Cortisol 8.5 NAD 2 1.23
Cortisol 7.4 NADP 2 0.84
''-Cortisone 7.4
NADH_ 
+ 1
n a d p h 2
2 0.09
■^Major conversion in this case to an unknown of approximately 30% 
of the substrate.
Table 5» Metabolism of cortisol and cortisone by kidney.
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DISCUSSION
It can be seen from the results of 11$-HSD assays in rat submandibular 
salivary gland homogenates that the reverse isotope dilution assay is the 
preferred analysis method. The homogenate contains too much particulate 
matter for the enzymes to be assayed by a spectrophotometric or fluorometric 
method. This is unfortunate because these other methods would have been 
less time consuming than the isotope method.
In the study of an enzyme reaction, the rate of the enzyme reaction 
should always be taken as the measurement of the initial rate, and this 
rate is obtained from the slope of the tangent to the reaction curve at 
zero time. It is only at the initial point that conditions are accurately 
known and limiting factors have not yet acted, e.g. the product of the 
reaction may inhibit the enzyme, the enzyme may be inactivated at the 
temperature or pH of the reaction, or the degree of saturation of the 
enzyme with substrate may fall because of the fall in substrate concentration 
as the reaction proceeds. The enzyme activity values in this report have 
been calculated from the measurement of the initial rate.
The effect of pH on enzymes, like all pH effects, is due to changes in 
the state of ionisation of the components of the system as the pH changes. 
Either the free enzyme, the enzyme-substrate complex or the substrate may 
undergo such changes. Since proteins and enzymes contain many ionisable 
groups, they exist in a whole series of different states of ionisation and 
the distribution of the total enzyme among the various ionic forms depends 
on pH and the ionisation constants of the various groups, and usually the 
catalytic activity is confirmed to a relatively small range of pH which is 
the optimal pH. The present study has revealed two optimal pH values, 
one with NAD as cofactor, the other with NADP as cofactor. This difference 
may be due to the nature of the cofactor used or ,there may be two separate !
I
enzyme systems, but the former proposition seems the more likely. j
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There is little mentioned in the literature on the optimal pH of 
11$-HSD in the various tissues as most workers carried out their investi­
gations at pH7.4« The histochemical method has a pH optimum of 7*0 - 7.2 
(Baillie et al., 1965c) whereas biochemical studies showed the pH optimum 
at pH9 - 10 (Meigs & Engel, 1961; Koemer & Heilman, 1964; Bush et al., 
1969; Koemer, I969). Histochemically, however, incubations at pH values 
greater than pH8 result in complications because of the so-called ‘nothing 
dehydrogenase1 (Pearse, i960).
Cofactors are organic substances of relatively low molecular weights 
(as compared to enzyme proteins) and in the case of NAD and NADP it is the 
specific function of hydrogen transfer with which they are important.
The amount of cofactor needed in the II3-HSD assay for submandibular 
salivary gland exceeds the cortisol substrate by 2,000 times and it is 
possible that there are enzymes in the homogenate which are degrading the 
cofactor, e.g. coenzyme nucleotidase, as well as enzymes still using 
intrinsic substrates. Koemer (1969) reported that NADPH^ was cleaved by 
dinucleotide nucleotidohydrolase which has been demonstrated in rat liver 
microsomes (Jacobson & Kaplan, 1957) and is known to act on NADPH . NAD 
is the preferred cofactor in submandibular gland and the cofactor preference 
of 11$-HSD in various tissues has been discussed in the General Introduction 
to this thesis. Filsell & Jarrett (I965) found a high (NAD.NADH )/ 
(^ADP.NADPH^) ratio of 10:1 in sheep parotid gland and propose that salivary 
gland prefers oxidative metabolism that leads to production of ATP as a 
source of energy for cation secretion.
The finding of the optimal temperature to be 37°C for the enzyme 
reactions has been dependent on the time during which the llg-HSD and 
cortisol are allowed to interact. As a general rule the shorter the 
reaction time the higher will be the optimal temperature whereas at a 
lower temperature, there the enzyme is more stable, the reaction will be 
slow but the final yield of product may be greater. Although the effects
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of temperature on the activity of enzymes are very complex and are inter­
related with other variables such as pH, buffer system and substrate con­
centration they present themselves as two forces acting simultaneously 
but in opposite directions. With increasing temperature the activity 
increases and at the same time inactivation (= denaturation of the enzyme 
protein) is accelerated. The higher the temperature, the more will 
inactivation dominate. This is the behaviour shown by both NAD- and 
NADP-linked 113-HSD1s. At 37°C the degrees of inactivation for 2 or 7 mins. 
incubations are not as great as at 50°C and 70°C. At 20°C the enzyme is
not as active as at 37°C for the incubation times chosen.
The "Michaelis Constant” is specific for an enzyme and substrate used
and the Km values shown in this present study of 0.48pM and 0.95pM for the
oxidation of cortisol, using NAD and NADP respectively, differ significantly 
from the value of 20pM found by Bush et al. (1968) for washed microsomes 
and acetone-dried powders of washed microsomes of rat liver under the 
conditions of spectrophotometric assay. Their st;udy confirmed the finding 
of Koemer & Heilman (1964) who found a Km of 30pM with acetone-dried 
powders of whole rat liver homogenate acting on cortisol. The probable 
reason for the difference in the Km values of the present study from these 
with rat liver is that 113-HSD in submandibular salivary gland has a 
different function from that in the liver.
The enzyme reaction is irreversible in the submandibular gland.
Cortisone is not metabolised and one of the possible functions of salivary 
gland may be to limit the amount of active steroid (cortisol) present in 
the gland, cortisone being potentially less active (Burton, I965). The 
liver enzyme is reversible (Hurlock & Talalay, 1959) but the kidney enzyme 
is not fully reversible (Mahesh & Ulrich, i960).
Corticosterone, the naturally secreted adrenocqrticoid in the rat, showed 
113-HSD activity when incubated with submandibular gland but the reaction 
was slower than with cortisol as substrate. Therefore the enzyme in the
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rat salivary gland utilises lift-, 17-hydroxylated steroids more readily. 
This agrees with histochemical findings (Dr M. M. Ferguson, Glasgow Dental 
Hospital, personal communication).
Kidney has previously been reported as a site for II3-HSD activity 
(Mahesh & Ulrich, I960; Baillie et al., 1965a). It, too, is an important 
gland concerned with water and electrolyte transport. The oxidation of 
cortisol to cortisone in the kidney appears to be the most important step 
for llft-HSD whereas the product formed by the reduction of cortisone was 
probably caused by the existence of 20-reductase or 20g-HSD in rat kidney. 
Mahesh & Ulrich (i960) have identified this product as 20-dihydrocortisone.
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SUMMARY
1. A reverse isotope dilution assay using cortisol-4-"^C as substrate was 
used to measure II3-HSD activity in male rat submandibular salivary gland 
homogenate, spectrophotometric and fluorometric methods being unsuitable.
The metabolite of the reaction was identified as cortisone by formation of 
derivatives and recrystallisation to constant specific activity.
2. The kinetic aspects of II3-HSD activity in submandibular gland 
homogenate were investigated. A variety of assay parameters were 
investigated to find the optimal conditions of enzyme activity. Nico­
tinamide adenine dinucleotide was the preferred cofactor to nicotinamide 
adenine dinucleotide phosphate with optimal pH conditions for the cofactor- 
linked enzyme being pH8.1 - 8.9 and pH7.6 respectively. A phosphate 
buffer was used to control pH as borate and tris buffers showed chemical 
reactions with the steroids. In the final assay volume of 11ml both 
cofactors were in saturing amounts at 1.25mM for lOOmg. of tissue (’enzyme1). 
The optimal temperature for the NAD- and NADP-linked II3-HSD was 37°C for 
incubations of 2 mins. and 7 mins. respectively (first order kinetics).
Km and Vmax for the NAD-linked II3-HSD were 0.48yM and 1.27n moles/min., 
the NADP-linked 11$-HSD values being 0.95pM and 0.37n moles/min. The 
substrate concentration chosen for enzyme assay was approximately 2xKm 
of the NAD-linked II3-HSD (lOn moles). Verification of the enzyme assay 
for lOOmg. gland homogenates was shown by increasingly proportional enzyme 
activity with ’enzyme’ (gland) concentration around this value.
3. Other steroid substrates were incubated with submandibular gland. 
Cortisone-4-^C could not be shown to metabolise although reduced cofactors 
and a variety of pH values and incubation periods were used. This showed 
that the enzyme reaction is irreversible. Corticosterone, the naturally 
secreted adrenocorticoid in the rat, was metabolised by the submandibular 
gland 113-HSD.
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4. 11$-HSD activity was investigated in rat kidney homogenate. Cortisol
was converted to cortisone, but cortisone was converted to a product other 
than cortisol indicating the difference between kidney and salivary gland 
metabolism of cortisone.
PART II
11B-HYDROXYSTEROID DEHYDROGENASE IN SUBCELLULAR 
COMPONENTS OF MALE RAT SUBMANDIBULAR SALIVARY GLAND
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PART II
118-HYPROXYSTEROID DEHYDROGENASE IN SUBCELLULAR 
COMPONENTS OF MALE RAT SUBMANDIBULAR SALIVARY GLAND
INTRODUCTION
1. Isolation of Subcellular Components.
The living cell is by no means a simple sac, but is in reality a 
system exhibiting complex structures when viewed under the microscope either 
in the living state or after fixation. The localisation of enzymes within 
the cell has been studied by two main methods: a) histochemical method:-
Ferguson (I967) and Ferguson et al. (1970) have dealt with the histochemistry 
of 113-HSD in salivary gland; b) separation of particulate fractions from 
disintegrated cells. Because of the isolation of II3-HSD in liver microsomes 
(Hurlock & Talalay, 1959; Bush, 1968; Koemer, 1969), whereas Mahesh & 
Ulrich (i960) found the highest activity in kidney homogenate was associated 
with the ultracentrifugal fraction containing nuclei and cell debris, it 
was decided to do biochemical studies on cell fractions of the rat sub­
mandibular salivary gland.
All fractionation experiments proceed in three steps: 1) homogenisation;
2) fractionation; 3) analysis of fraction for enzyme. By subjecting tissues 
to conditions of high shear in the appropriate media it is possible to 
retain the morphological and cytological properties of the particulate 
components of the cell. This cell-free preparation is called a homogenate.
The homogenate can then be centrifuged and various cellular components 
isolated. The nuclei sediment first, followed by the mitochondria. High 
speed centrifugation (l00,000g or more) causes a fraction made up of granules, 
called the microsomal fraction, to sediment. The standard scheme of 
fractionation did not develop until the work of Dounce (1943) t Claude 
(1946a, b) and Hogeboom et al. (I948).
In the analysis of the tissue fractions first we must identify the 
fraction by examination of unfixed and unstained material wherever possible, 
supplemented by observations employing staining methods and examination in
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the electron microscope. Secondly, there is the essential requirement of 
a balance sheet when studying the enzyme associated with the subcellular 
elements (Schneider & Hogeboom, 1951)• The amount of enzyme activity in 
each subcellular fraction is expressed as a percentage of the amount in the 
original homogenate. This provides an indispensible test of the validity 
of results.
A. Centrifugation.
Fractionation of cell components by means of centrifugation is possible 
because particles which differ in size (or shape) and density will sediment 
at different rates when under a centrifugal force. Centrifugation has 
received extensive theoretical treatment. Particle behaviour in a 
centrifugal field and their sedimentation rates have been reviewed by 
several authors (Svedberg & Pedersen, 1940; Ogston, 1956; Schachman, 1959)* 
There are two main types of centrifugation:
(l) Differential Centrifugation.
This type of centrifugation depends on the various structural 
components of a homogenate sedimenting at different rates, according to 
the size and density of the particles. The method is most successful 
when the differences in the sedimentation rates are large. By suitable 
choice of speeds the sedimented fractions can be arranged to contain, 
successively, whole cells and cell debris, nuclei, mitochondria etc., 
and microsomes, the final supernatant fluid containing soluble con­
stituents . Several articles have dealt with the theoretical and 
practical aspects of this technique (Pickels, 1943$ De Duve & Berthet, 
1954$ Allfrey, 1959). There are limitations of the technique, 
however. In differential centrifugation, fractions are collected 
consecutively at the bottom of the centrifuge tubes but, in practice, 
the species purity is usually lower than predicted. This is due to 
wall effects where the particles adhere to the wall of the centrifuge 
tube and set up convection currents as they travel down the wall with
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a loss of resolution in the predicted purity of the fraction. In a 
similar manner, thermal convection currents can be set up at high 
centrifugal speed, but refrigeration of the centrifuge head largely 
eliminates this problem.
(2) Density Gradient Centrifugation (first used by Brakke, 1951).
In this method separations are achieved by virtue of difference 
in the density of the particles. A mixture of particles can be 
separated into several fractions which differ in specific gravity by 
centrifuging them through a density gradient until each species finds 
its own density level. The technique can be used in ’cleaning up1 
nuclear fractions by layering the nuclear suspension over a medium of 
higher density which acts as a barrier to particles of low specific 
gravity and permits the denser nuclei to pass to the bottom of the 
tube.
The uses of density gradients have been detailed in several 
reviews (Anderson, 1956; De Duve et al., 1959; Beaufrey & Berthet, 
1963). This technique, also, has limitations. These include wall
effects, difficulty in stabilising the density gradient and small
rotor capacities. Several of these difficulties have been overcome 
by the advent of a new system for density gradient centrifugation, 
the zonal centrifuge (Anderson, 1966a, b; Bimie, 1969; Reid, 1971) 
in which the following ideal conditions exist:
a. minimal wall effects
b. much greater rotor capacities
c. a stabilised gradient which is rapidly introduced into,
and recovered from, the rotor with minimum disturbance 
and loss of resolution
d. a sharp initial zone
e. a variety of rotors, some of which are capable of high
speeds
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B. Isolation of Nuclei.
Many methods have been proposed for the isolation of nuclei but there 
are deficiencies in most of the methods, e.g. low yields, denaturation, 
contamination by other cell components and morphological alterations 
(Bounce, 1955; Roodyn, I969). There is no ideal method for isolating 
intact, uncontaminated nuclei suitable for metabolic and chemical studies.
Citric acid containing solutions have been among the most popular 
for the isolation of nuclei (Bounce, 1943)* This method is good if purity 
and ease of preparation of the fraction are important but a number of 
enzymes are inactivated by this method.
Another method for the isolation of nuclei involves the use of organic 
solvents. This method was originally proposed by Behrens (1932). The 
method was used for the study of soluble enzymes of the nucleus and the 
enzymology of the nucleus has been surveyed in great detail by Georgiev 
(1967) who discussed the advantages and disadvantages of using organic 
solvents for isolating nuclei. There is still considerable doubt about 
the significance of studies on nuclei prepared in organic solvents because 
this treatment has considerable effect on the morphology of other cytoplasmic 
particles.
Most metabolic studies on nuclei have been with nuclei isolated by the 
techniques of Hogeboom et al. (1952) or Stirpe & Aldridge (1961). These 
methods involve a layering technique where homogenates in 0.25M Sucrose - 
Salt solution are layered over 0.34M Sucrose - Salt solution and centrifuged 
at 600g/l0 mins. The pellet is then resuspended in 0.25M Sucrose - Salt 
solution, relayered and centrifuged twice more for purification of the 
nuclear fraction. Dense sucrose methods (Chaveau et al., 1956; Maggio et ah, 
1963) have been used to isolated nuclei for metabolic studies. Due to the 
high density of the medium, 2.2M, only nuclei sediment at high speed 
centrifugation, 40 >OOOg, and all the cytoplasmic contaminants float.
These methods yield nuclei of high purity. A drawback, however, of using
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dense sucrose is that many enzyme systems are inactivated by its use.
If the preservation of morphology is essential, more complex salt media as 
in the method of Maver et al. (1952) may be required.
There have been an increasing number of papers in which various 
detergents have been used for isolating nuclei (Hubert et al., 1962;
Rappoport et al., 1963; Holtzman et al., 1966). The nuclei isolated 
appear to be pure but a drawback of using detergents is that hydrolytic 
enzymes are released by their use.
C. Isolation of Mitochondria.
Warburg demonstrated in 1913 that cellular respiration is associated 
with sedimenting particles. This cellular respiration is caused by 
mitochondria. However, it was not until the work of Schneider & Potter 
(1949) and further research that it was found that mitochondria 
are the main sites of cellular oxidations and phosphorylations. Be Duve et al. 
(1955) have shown that the ’mitochondrial1 fraction contains, in addition 
to true mitochondria, particles of a second kind to which the name lysosomes 
has been given. Estabrook & Pullman (1967) have an extensive article on 
the preparation of mitochondria from a wide variety of cells, tissues and 
organisms.
In the method of Schneider & Hogeboom (1950) the 0.25M Sucrose 
supernatant from the nuclear fraction of rat liver homogenate is collected 
and spun twice for 10 minutes at 5>000g, the pellet is resuspended and 
spun twice for 10 minutes at 24*OOOg. Microscopic examination of this 
fraction showed that it contained mitochondria alone.
C. Isolation of Microsomes.
The term ’microsomes* does not refer to a discrete cytoplasmic organelle. 
It denotes the particulate fraction that sediments upon centrifugation at 
speeds exceeding 100,OOOg (Be Duve, 1964; Reid, 1967). The tern 
’microsomes* refers to a mixture of membraneous elements and ribosomes.
• - 4 9 -
The most successful procedure for isolating microsomal fractions is 
that of differential centrifugation by a method devised by Palade & 
Siekevitz (1956). Reid (1967) has written an historical account of the 
problem. The method involves the prior separation of nuclei and mito­
chondria from the tissue homogenates by low speed centrifugation followed 
by ultracentrifugation of the supernatant at 100,OOOg or more for 1 - 2  hrs.
Many important discoveries have been made from the studies on micro­
somes, e.g. identification of the ribosomes as the main centres of protein 
synthesis (Littlefield et al. , 1955; Palade & Siekevitz, 1956).
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MATERIAL AND METHODS
1. Preliminary Fractionation Technique.
Unfasted male Sprague - Dawley rats weighing 200-250g, fed on 
commercial diet 41B, were used. The rats were killed by neck dislocation, 
and the submandibular glands removed and placed on ice. The glands were 
trimmed of fat and weighed. Scissors were used to chop the glands finely 
and a 10^ (w/v) homogenate in 0.25M-0.88M Sucrose was prepared with 6 strokes 
of a teflon - glass homogeniser at l,000rpm. A homogenate prepared in
0.88M Sucrose/0.02^ STI (Soybean Trypsin Inhibitor from Sigma, London) 
retained activity for 24 hours whereas without STI lost 11$-HSD activity 
in 4 hours.
Subcellular particles were prepared as follows:- 20ml of homogenate 
was pipetted into 2xlQml graduated centrifuge tubes and centrifuged at 
700g for 10 mins. to sediment the ’nuclear1 fractions which were suspended 
in 2x10ml O.88M Sucrose. The supernatants were transferred to 25ml 
polycarbonate tubes and centrifuged at 15,000g for 20 mins. in an MSE 
Superspeed 50 Ultracentrifuge. The sediment in this fraction was desig­
nated as the ’mitochondrial' fraction.
The sediments were resuspended in 2x10ml O.88M Sucrose and the 
supernatants from this fraction were then put in other polycarbonate 
tubes and spun at 105>000g for 1 hour in the ultracentrifuge. The 
sediment from this spin resulted in a 'microsomal' particle deposit. This 
deposit was also made up to 2x10ml volume. The three fractions were 
processed and photographed by the E/H (electron microscopy) technique 
described on p. 53. The supernatant of the 105,000g/hour fraction was 
made up to 2x10ml volume and designated as the soluble fraction. 1ml 
aliquots (lOOmg. homogenate equivalents) of all the fractions were taken 
for 11$-HSD assay (p. 54). Protein estimations were carried out according 
to the method on p. 52.
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2. Revised Fractionation Technique.
There are several drawbacks in the preliminary fractionation technique 
and these were cleared up by this revised fractionation technique (Fig. 11). 
Submandibular glands of male rats were chopped finely and weighed. The 
homogenate was prepared by 6 strokes with a tightly fitting teflon pestle 
at l,000rpm in 0.88M Sucrose, 1.5 MCaCl , 0.02$ STI at a 10$ concentration 
(w/v). It was then filtered through 4 layers of surgical gauze. This 
eliminated whole cells, cellular and gland debris, and precipitated protein.
A looser fitting pestle produced too many whole cells and gland debris 
and the use of an Ultra-Turrax homogeniser disintegrated the subcellular 
structures. A nuclear fraction was produced by centrifugation at 600g 
for 10 mins., the zymogenic and mitochondrial fraction by centrifugation at 
4,OOOg for 10 mins,, the microsomal fraction at 75*OOOg for 30 mins. and the 
supernatant from this being the soluble fraction. Electron micrographs 
were taken of the three fractions by the method described on p. 53 and 
113-HSD activity assayed by the modification on p. 54* The procedure 
for protein estimation was after Lowry et al. (1951) (p* 52).
3. Nuclear Isolation and Nuclear Membrane Solubilisation.
Submandibular salivary gland nuclei were prepared according to the
technique illustrated in Fig. 12. A 10$ (w/v) homogenate was prepared by 
homogenising freshly chopped submandibular gland in 0.25M Sucrose,
5x10 MgCl^ and 0.02$ STI with 6 strokes of a teflon-glass homogeniser at 
l,000rpm, followed by filtration through 4 layers surgical gauze and re­
constitution to a 10$ (w/v) concentration. A crude nuclear fraction was 
then prepared by centrifuging the homogenate at 600g for 10 mins., the 
operating temperature being 0°-2°C. A portion of the crude nuclear pellet 
was kept for 11$-HSD assay. The supernatant was discarded and the pellet 
rehomogenised in 1.8M Sucrose, 5x10 ^M MgCO^ and 0.02$ STI. This mixture 
was spun at 40,OOOg for 1 hour in an MSE Superspeed 50 Ultracentrifuge.
The pellet obtained in this spin was washed three times with 0.25M Sucrose
Difforcntlal ccntrifngntlon of SMSO- 
subcellular particles.
10$ (w/v) Homogenised gland in. 10ml 0.88M Sucrose, 1.5mM CaCl^* 0.02$ STI
Filtered through 4 layers surgical gauze
I
Nuclear Fraction
600g/l0 mins.
Supernatant
4,000g/l0 mins.
Zymogen granules, 
Mitochondria, 
Lysosomes
Supernatant
£
75,000g/30 mins,
Microsomes Soluble
Figure 12. Method used for isolation of SMSG nuclei.
10$ ('.y •' homogenate in 0.25M Sucrose, 5x10 MgCl , 0.02$ STI 
Filtered through A layers surgical gauze
600g/l0 mins.
Crude Nuclear Fraction Pellet— ^Supernatant discarded
Treat with 
detergent and 
spin at 600g/ 
10 mins.
S /
Detergent Nuclei N /
Rehomogenise in 1.8M Sucrose, 
 5xlO“3M MgCl2, 0.02$ STI
Spin at 40,000g/hr.
Pellet— ^ Supernatant discarded
 Wash 3 times with 0.25M Sucro
Pure Nuclei
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and suspended as a 10$ (w/v) homogenate equivalent. Samples of the pure 
nuclei obtained were processed for electron microscopy according to the 
method described (p. 53). Aliquots were taken for II3-HSD assay (p. 54).
The solubilisation of the nuclear membrane could be obtained by 
treating the crude nuclear fraction with detergent, Triton x-100 (a non­
ionic detergent). To the crude nuclear fraction a Triton x-100 solution 
was added in the concentration of 0.1$ and mixed for 1 min. by a vortex 
mixer. This mixture was spun at 600g for 10 mins. and the detergent nuclei 
pellet obtained. Sodium deoxycholate and Tween 80 were also used as 
detergents, the same effect being noted as with Triton x-100.
Use of a hypotonic medium, such as water, as used by Neville (i960) 
to break the nuclear fraction into membraneous components was used to 
investigate the possibility of II3-HSD activity in the membraneous components 
of the nuclear fraction.
4. Isolation of Salivary Gland Tubules by Collagenase.
A modification of the procedure of Burg & Orloff (1962) for kidney 
tubules was used as follows: lg of submandibular salivary gland was
chopped finely and immersed in 4 volumes of isotonic saline. 0.1$ Soybean 
Trypsin Inhibitor and 0.1$ collagenase (Sigma, London) were added to the 
mixture and incubated at room temperature. This mixture was passed 
through gauze and the tubules centrifuged at 50g for 90 seconds. The 
tubules were identified by light microscopy and 500mg. gland equivalents 
were incubated with cortisol-4-^C for 15 mins. in order to estimate 
II3-HSD activity.
5. Assay for Protein.
The measurement of protein in the homogenate and subcellular fractions 
was performed using the method of Lowry et al. (1951). They have 
suggested that the application of the copper-Folin reaction includes the 
measurement of protein during enzyme fractionations. It is 10 or 20 times 
more sensitive than measurement of the ultraviolet absorption at 280nm
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and is much more specific and much less liable to disturbance by turbidities. 
It has the advantage of simplicity and sensitivity in use.
Method: All the chemicals were purchased from B.D.H., Dorset. Reagent A,
2% Na^ CO^ in 0.10N Na OH. Reagent B, 0.5% Cu SO^ *5^0 in 1% sodium 
tartrate. Reagent C, alkaline copper solution. Mix 50ml of Reagent A 
with 1ml of Reagent B. Discard after 1 day. Reagent D not used.
Reagent E, diluted Folin reagent. Titrate Folin - Ciocalteu phenol 
reagent with NaOH to a phenolphthalein end-point. The titration carried 
out made it 3»2N and the Folin reagent was diluted accordingly to make it 
IN in acid. The standard protein solution prepared was lmg./ml of 
crystalline bovine serum albumin. This was checked against a human serum 
albumin equivalent.
To a sample of 5 to lOOpg of protein in lOOpl or less in a 10ml test
tube, 1ml of Reagent C was added, mixed and allowed to stand for 10 mins. or
longer at room temperature. 0.1ml of Reagent E was added very rapidly 
and mixed immediately. After 30 mins. or longer, 2ml of distilled water
was added and the sample was read in an S.P. 500 spectrophotometer at
500nm. The concentration of the protein in the samples was calculated 
from a standard curve constructed using known amounts of protein, 10pg,
25hg, 50pg, lOOpg.
6. Processing Cycle for Electron Microscopy.
All the chemicals were purchased from B.D.H., Dorset unless otherwise 
stated. 2% Glutaraldehyde (Taab Laboratories, Reading) in 0.2M sodium 
cacodylate buffer pH7.2,osmotic pressure 300 mOsm. 1% Osmium tetroxide 
(Taab Laboratories, Reading) in 0.2M sodium cacodylate buffer with 5*5% 
sucrose added pH7.2,osmotic pressure approximately 250 mOsm.
Processing Sequence: Glutaraldehyde fixation of subcellular fraction
pellets for 2 hrs. Wash in buffer for 1 hr. (0.2M sodium cacodylate pH7.2). 
Postfix in osmium for J hr.
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Rinse in distilled water.
Dehydration in 50% alcohol for 5 mins., 75% alcohol for 5 mins.,
95% alcohol for 5 mins., absolute alcohol, three changes of 10, 10 and 
20 mins. each.
Soaking Mixture:- 50% Propylene oxide with 50% Araldite for 30 mins. 
then add Araldite to give a 66/34 mixture, for 1 to 4 hrs. Araldite 100% 
■leave at room temperature for 5 to 8 hrs. Embed and incubate for 48 hrs. 
at 60°C. (Araldite - Durkapan, manufacturer Fluka, Basle.)
Examination: 90nm sections were prepared on an MT 2B Sorvall Ultra­
microtome and mounted on Formvar coated grids stabilised with carbon 
coating. The sections were stained in saturated uranyl acetate for 
15 mins., washed and stained for 4 mins. in lead citrate (Reynolds, I963). 
The sections were then examined in an EM 6B electron microscope.
7. Modification of llfl-HSD Assay.
Subcellular fractionation depends on various concentrations of sucrose. 
The subcellular fractions were made up of 0.25-0«88M Sucrose and sometimes 
isotonic saline in order to maintain structural integrity. However, the 
homogenate was made up as 10% (w/v) for the fractionation experiments 
compared with 1% (w/v) for the kinetic experiments. Therefore lOOmg. 
equivalents in sucrose of tissue homogenate or subcellular fractions were 
added to the 11$-HSD assay (p. 27) and the volume of phosphate buffer 
altered accordingly. The final volume in the assay consisted of 1ml of 
lOOmg. tissue equivalent in sucrose or saline, 8.95ml of 0.067M phosphate 
buffer, 0.05ml of substrate dissolved in propylene glycol and 1ml of NAD 
(13.8y moles) in final volume of 11ml.
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RESULTS
1. Inactivation of llfi-HSD in Submandibular Salivary Gland Homogenate.
A. Effect of Temperature.
It is of interest to see what conditions a) freezing (-15°C); 
b) refrigeration (0-5°C); c) room temperature (20°C) impose on NAD-linked 
II3-HSD activity after 3 days at these temperatures in a sucrose homogenate. 
Assays were performed for 113-HSD activity (pp. 27 and 54) on these three 
parameters. Freezing (-15°C) retains almost total activity after 3 days 
but at 5°C and 20°C no activity is retained after 3 days. An incubation 
of homogenate kept frozen 10 days revealed a total loss of activity.
B. Effect of Time.
In initial experiments for the assay of llg-HSD activity in subcellular 
fractions of submandibular gland there was a total loss of enzyme activity 
within 8 hrs. of the excision of the gland, even though the homogenate and 
subcellular fractions were kept on ice at 0°C during this time. It was 
essential therefore to follow the rate of enzyme denaturation in gland 
homogenate at 0°C. 113-HSD assays were performed on sucrose homogenates
of rat submandibular gland which were kept on ice at 0°C for 0 mins., 1 hr.,
2 hrs., 3 hrs., 5 hrs., 6 hrs., 7 hrs., 8 hrs., 9 hrs. for both NAD- and 
NADP-linked II3-HSD. The enzyme activity was plotted against time of 
homogenates at 0°C and the resultant graphs are shown in Fig. 13. The 
113-HSD is inactivated within 8 hrs. of preparing the homogenate. Fraction­
ation processes usually take about 3 hrs. and the maximum retention of 
activity is preferable. The use of 0.02% Soybean Trypsin Inhibitor gave 
a better retention of II3-HSD activity in the homogenate (Fig. 13).
2. 116-HSD in Subcellular Fractions.
A. Preliminary Fractionation.
The main 113-HSD enzyme activity was located in the crude nuclear 
fraction. A balance sheet of the II3-HSD activities recovered in the 
fractions of this technique is shown in Table 6. The electron micrographs
Figure 13. Inactivation of 113-HSD in submandibular gland 
homogenate at 0°C.
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TIME (hrs)
Fraction Activity
(Units)
or/o
Activity
mg Protein/ 
lOOmg gland
Specific
Activity
!
Relative j
Specific
Activity
Homogenate 1.275 100 13.583 0.0938 1
700g/l0 mins. 
Crude Nuclear 
Fraction
0.885 69.4 5.463 0.1619 1.726
15*000g/20 mins. 
Zymogen Granule 
Mitochondrial 
Microsomal 0.229 11.9 3.17 0.072 0.7675
Lysosomal
Fraction
105,000g/hr.
Ribosomal
Fraction
0.113 5-9 1.34 0.0842 0.8976
Soluble 0.131 10.3 4.17 0.0314 0.3344
Table 6, 11B-HSD in SMSG subcellular particles isolated by initial 
differential centrifugation technique in 0.88M Sucrose/0.02$ STI (in mole 
conversion of cortisol to cortisone/minute = 1 unit of 11$-HSD activity).
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of the fractions are shown in Figs. 14-16. The nuclear fraction is very 
crude, composed mainly of nuclei, but also containing erythrocytes, unbroken 
cells and collagen. The 'mitochondrial* fraction is heavily contaminated 
with microsomal particles and lysosomes whereas the 'microsomal' fraction 
is a pure fraction of ribosomes.
B. Revised Fractionation.
The main 113-HSD enzyme activity was located in the crude nuclear 
fraction and Table 7 shows the balance sheet of the II3-HSD activity in 
the fractions. The nuclear fraction does not contain whole cells in this 
case as these were retained by the surgical gauze (Fig. 17). The 
mitochondrial fraction (Fig. 18) only contains secretory granules and 
mitochondria and shows no contamination by microsomal particles which are 
seen in the microsomal fraction (Fig. 19). The relative importance of 
mitochondria or microsomes in II3-HSD metabolism in submandibular gland 
can therefore be discounted as there is little activity in these particles.
C. Isolation of Nuclei and Nuclear Solubilisation.
The crude nuclear fraction obtained in the revised fractionation 
technique can not be considered a pure preparation of nuclei because of 
the contaminating cellular debris. No II3-HSD activity was observed in 
the solubilisation method of Neville (i960), the II3-HSD not even being 
present in a lysed homogenate.
A nuclear fraction formed by passing crude nuclei through a 1.8M 
Sucrose can be considered to be pure morphologically as shown by electron 
microscopy (Fig. 20). The nuclei would not sediment through a 2.2M 
Sucrose. The detergent treated nuclei show a pure nucleoprotein fraction 
(Fig. 21), the nuclear membranes having been solubilised by the detergent.
The relative specific activity of the 113-HSD was present in higher 
amounts in the three nuclear fractions than in the filtered homogenate 
(Table 8). The crude nuclei showed the highest relative specific activity, 
followed by the pure nuclear fraction and lastly the detergent treated
Electron-micrograph of a nucleus (N) with 
adjoining whole cell (A) and collagen (c)\

Figure 15. Mitochondrial1 (M) fraction prepared at 15,000g 
for 20 minutes showing gross contamination by 
microsomal particles (Me).
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Figure 16. Ribosomes isolated as the Microsomal1 fraction 
from the preliminary fractionation technique.
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Fraction Activity
(Units)
ofn /0
Activity
mg Protein/ 
lOQmg Gland
Specific
Activity
Relative 
Spe ci.f ic 
Activity
Filtered 
Homogenate 
Through 4 
Layers Surgical 
Gauze
1.0921 100 13.0 0.0840 1.00
600g/l0 mins.
Nuclear
Fraction
0.6065 55.5 4.1 0.1479 1.76
4,000g/l0 mins. 
Zymogen Granule 
Mitochondrial 
Fraction
0.1820 16.7 2.5 0.0728 0.87
75,OOg/30 mins.
Microsomal
Fraction
0.1213 11.1 2.0 0.0606 0.72
Soluble Fraction 0.1213 11.1 4.2 0.0280 0.33
Table 7. 11$-HSD activity in SMSG subcellular particles isolated by
revised differential centrifugation method in 0.88M Sucrose, 1.5mM 
CaCl2, 0.02^ STI.
Figure 17. Crude nucleus (N) isolated by revised fractionation 
technique showing cellular debris contamination.
/

Figure 18. Mitochondria (M) and Zymogen Granules (Z) 
isolated at 4>000g for 10 minutes.

30 minutes.

Figure 20. Pure Nuclei (N) isolated through a l.SM Sucrose 
solution.

Figure 21. Nuclooprotein isolated, from a detergent treated 
crude nuclear fraction.
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Fraction
........ "
Activity %Activity
... ..... 1
mg Protein/ 
lOOmg Gland
Specific
Activity
Relative
Specific
Activity
Homogenate 1.1322 100 13.5 O.O838 TJ-
Crude Nuclear 
Fraction 0.805 71.1 5.9 0.1364
1.628
Detergent
Nuclei 0.3129 27.6 3.2 0.0977 1.166
Pure Nuclei 0.50 44.2 4.0 0.1250 1 .49
Table 8. 11B-HSD activity in SMSG nuclei isolated as in Fig. 12.
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nuclei. The major activity of 113-HSD in submandibular salivary gland 
is therefore located in the nucleus.
The activity in the nucleoprotein isolated by detergent could possibly 
be higher than it was but there may have been slight enzyme denaturation 
using the detergent method. Since the enzyme's relative specific activity 
in nuclei is not all that much greater than in homogenate there is probably 
also a minor interaction with other cell components in the neo-nuclear area 
which might be related to the possibility that the enzyme is involved in 
genome expression (see Discussion p. 60).
3. 113-HSD in Submandibular Gland Tubules.
The submandibular gland tubules were isolated by the use of the enzyme, 
collagenase. This degraded the layer of collagen which surrounds the 
salivary gland ducts and collagen probably accounts for the toughness of 
the tissue.
The activity of the II3-HSD in the isolated tubules was minimal 
compared with the activity which would have been found in the submandibular 
homogenate.
Therefore, although duct cells exhibit the histochemical localisation 
of 113-HSD (Fig. 22) the isolation of tubules does not lead to a more 
purified preparation of 113-HSD than the gland homogenate.
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DISCUSSION
Proteases and nucleases are released by homogenisation (Robinovitch 
et al., 1969) and this accounts for the fast degradation of 113-HSD in the 
homogenate which was slowed down by the addition of a protease inhibitor, 
Soybean Trypsin Inhibitor (Fig. 13). Hirose et al. (1971) examined the 
hydrolytic enzymes of the salivary glands. They found that rat sub- 
maxillary gland has high protease activity at pH7.5 and they separated 
five protease fractions with different properties from the gland.
In order to preserve structure of cell components any pressure during 
homogenisation has to be avoided. Feinstein & Schramm (1970) used a very 
loose fitting pestle (0.8mm clearance) for the preparation of rat parotid 
gland mitochondria. However, Horak & Pritchard (1971) could not apply 
the procedure to submandibular gland tissue. The present study has shown 
that the use of the tighter fitting pestle is preferred to the use of the 
looser fitting pestle as with the latter there is too much wastage of 
tissue in the filtration of the homogenate.
Salivary gland is a very tough tissue with a high content of calcium
which reportedly disrupts salivary mitochondria (Feinstein & Schramm, 1970))
and makes the isolation of intact, functioning mitochondria rather 
difficult. The present morphological study of the mitochondrial fractions 
(Figs. 15 and 18) shows the mitochondria appearing to be slightly broken up, 
but not to a significant extent because there is quite a high content of 
intact mitochondria in Fig. 18. Horak & Pritchard (1971) in the pre­
paration of submandibular gland mitochondria used a modification of the 
method of Chance & Hagihara (1963) where a brief digestion of the tissue 
with a bacterial protease precedes homogenisation.
The use of collagenase in the present study to break down the tissue 
with the intention of isolating salivary ducts and tubules with an 113-HSD 
was not successful. Burg & Orloff (1962) had isolated kidney tubules for 
the purpose of studying reabsorption phenomena. They had injected
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collagenase solution (0.375%) into the renal arteries of excised rabbit 
kidneys and incubated the diced cortex obtained from these kidneys in the 
collagenase solution for 45 mins. at room temperature. The mixture was 
passed through surgical gauze and the tubules were centrifuged at 50g for 
90 seconds. The absence of II3-HSD in the collagenase treated salivary 
glands can be accounted for in three ways.
1. The collagenase solution may have contained contaminating 
proteases which were not inactivated by the Soybean Trypsin Inhibitor 
and therefore inactivated the 11$-HSD.
2. Collagenase has been reported as being an 1antimorphogenetic* 
agent for salivary epithelium (Grobstein & Cohen, 1965) and this may 
have a detrimental effect on llft-HSD metabolism.
3. Osinski (i960) reported that the 11$-HSD of human placenta was 
bound to connective tissue and Berliner & Dougherty (1961) found that 
fibroblasts contained the enzyme and therefore the use of collagenase 
may have disrupted the enzyme-tissue link.
The preliminary fractionation technique was a universal technique used 
for liver, first brought about by Schneider & Hogeboom (1950)1 whereas the 
revised fractionation technique used similar centrifugal speeds to those 
used by Pritchard et al. (1971) to isolate the mitochondrial and zymogen 
granule fraction and the microsomal fraction of rat submandibular salivary 
glands. The liver is different from submandibular gland in the composition 
of cells, the liver being relatively easy to homogenise whereas the sub­
mandibular gland is not.
There is no standardisation of technique for the isolation of nuclei 
with the liver and the comparison of the prostate and submandibular glands 
in structure and toughness of tissue is more appropriate. For this reason 
the submandibular gland nuclei were isolated by a method similar to Grant 
et al. (1970) (after Sierralta & Minguell, 1970) for the isolation of 
prostatic nuclei, but a few modifications were made. The nuclei were
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found to be the major site of II3-HSD activity. Mahesh & Ulrich (i960) 
found the enzyme present in nuclear particles and microsomes but could not 
find the enzyme present in pure nuclei.
Lang (1971) has reported that for the steroid hormones, ecdysone and 
cortisol, a primary action in the nucleus is evident. By some not yet 
understood mechanism the RNA polymerase activity is stimulated. In 
consequence of this there is an increase in RNA synthesis and a part of 
the newly synthesised RNA can be regarded as an m RNA (messenger ribo­
nucleic acid) which carries the information for the synthesis of specific 
proteins. It can be assumed that this m RNA controls enzyme synthesis 
in the cytoplasm. Grant (1969) has, however, doubts about the intervention 
of steroid hormones in the processes of translation of the genetic message. 
It can only be proposed that 113-HSD may have an effect on the 
genetic expression of submandibular gland cell processes but further 
extensive work would have to be undertaken to substantiate this view.
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SUMMARY
1. 113-HSD was studied in intracellular components of the rat submandibular
salivary gland, using NAD as cofactor. The relative difficulty in obtaining 
pure subcellular particles has been overcome and llg-HSD was found to have 
its main activity in the crude nuclear fraction of the gland. Nuclei were 
isolated using 1.8M Sucrose and these were found to retain the major enzyme 
activity. Attempts to solubilise the nuclear enzyme using detergent and 
hypotonic solutions were unsuccessful. The enzyme in the salivary gland 
may influence nucleic acid metabolism but further work will have to be 
undertaken to investigate this possibility.
2. Rat submandibular gland is a tissue of differentiated cell types.
It was therefore considered important to investigate the activity of 11$-HSD 
in separated tubules using the enzyme, collagenase, to break up the gland. 
However, little activity was recovered in the tubules probably because the 
collagenase used included a number of protease and peptidase impurities.
PART III
ENZYME HISTOCHEMISTRY IN SUBMANDIBULAR GLAND
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PART III
ENZYME HISTOCHEMISTRY IN SUBMANDIBULAR GLAND
INTRODUCTION
1. Salivary Gland Enzymes.
Amylase is the only enzyme which plays an important part in digestion.
It is produced by the salivary glands, mainly the parotid gland. Amylase 
is a combination of two enzymes; “ -amylase which hydrolyses dextrans and 
lowers saliva viscosity, and 3-amylase which breaks down large carbohydrates 
into smaller fractions, usually maltose. This enzyme consists of about 
12^ of the total amount of organic matter in saliva. Among other carbo- 
hydrases produced by the salivary glands are 3-glucuronidase (Chauncey, 1961) 
and 3“galactosidase found in rat submaxillary gland by Sukeno et al. (1972).
Alkaline phosphatase is present in salivary glands and histochemically 
the enzyme has been found irregularly by various workers (Noback & Montagna, 
1947; Junqueira et al., 1949; Hill & Bourne, 1954). Acid phosphatase 
can be identified in both duct and acinar cells. Aliesterases hydrolyse 
esters of short chain fatty acids and these were found in the duct cells of 
different glands (Hill & Bourne, 1954). Lipases which attack the glycerides 
of long chain fatty acids were found by Martin (1953) in the interlobular 
ducts of dog submaxillary glands.
Cholinesterase is found mainly in the nerve fibres of the salivary 
gland. The density of stained nerve fibres which surrounds the main ducts 
was much less in the sublingual than in the submaxillary gland (Snell & 
Garrett, 1957).
Amino peptidase has been demonstrated in the interlobular ducts of 
the human parotid and submaxillary glands (Burstone & Folk, 1956). 
Transferring enzymes catalyse reactions in which a chemical group is 
transferred from one compound to another. Peroxidase, which is present in 
the salivary glands, contains iron and requires hydrogen peroxide as its 
hydrogen acceptor. Succinic dehydrogenase has been found in high con-
- 63 -
centrations in the duct cells of the rat, guinea pig and rabbit with much 
less enzyme in the acinar cells (Padykula, 1952; Hill & Bourne, 1954). 
Pritchard et al. (1971) found fatty acid CoA synthetase activity and highly 
active palmityl-CoA-carnitine transferase in the mitochondrial and microsomal 
fractions of rat submandibular glands. Their study indicated that SMSG 
subcellular fractions possessed a capacity for rapid lipid formation.
They used a variety of enzyme markers for their subcellular fractions, 
namely: succinic dehydrogenase for mitochondria; glucose-6-phosphatase
for microsomes; 5-nucleotidase for plasma membrane; p-nitrophenylphos- 
phatase for plasma membrane and nuclei; 3-glucuronidase for lysosomes; 
adenyl cyclase and galactosidase for plasma membrane. Recently, Sukeno 
et al. (1972) have made an enzymic characterisation of golgi - rich fractions 
from rat submaxillary and sublingual glands. Each fraction was character­
ised by enzyme markers, including three glycosyltransferases: galactosyl- 
transferase, N-acetylglucosaminyltransferase, and N-acetylgalactosaminyl- 
transferase. NADPH« diaphorase, an enzyme bound to smooth membrane was 
not detected either in the homogenate or in the subcellular fractions.
Horak & Pritchard (1971) reported on the preparation of coupled mitochondria
from submandibular gland and their capacity for fatty acid oxidation.
+ +
Filsell & Jarrett (1965) have discovered a highly active Na, K-ATPase enzyme 
system in the parotid gland and support the contention that active cation 
transport does occur in salivary glands and may be involved in the secretory 
process.
Other enzymes present in salivary glands are lysozyme, whose con­
centration in saliva is 8 times higher than in blood serum, carbonic 
anhydrase and aldolase. Sreebny & Meyer (1964) have reported the presence 
of a protease present in the convoluted tubules of the rat submaxillary 
gland. Junqueira et al. (1964) also noted the presence of protease in 
rat submaxillary gland.
Of the steroid enzymes found in salivary glands, Ferguson (1967) has
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reported 113-HSD present in the cells of the striated, intralobular and 
interlobular ducts of rat, mouse and rabbit parotid and submandibular glands. 
No other hydroxysteroid dehydrogenases were found. Rosner et al. (1965), 
however, reported biochemically that rat submaxillary gland showed, 178- 
hydroxylase, A^-38-HSD and desmolase activity. The parotid glands
and pancreas did not share these enzymic activities. Katkov et al. (1972) 
found A^-33-HSD-isomerase activity in boar salivary glands. Rosner et al. 
(1969) also demonstrated that the submaxillary glands of rat had all the 
enzymic mechanisms required to convert acetate to cholesterol in vitro and 
a C20 22 desmolase activity was observed. Recently, Cardinali et al.
(1971) have shown that rabbit and human submaxillary glands have 173~ and 
203-steroid reductase activity and Baldi & Charreau (1972) have reported 
a 173-HSD in rat submaxillary gland.
2. Advantages of Histochemistry.
The undeniable advantage that tissue histochemical methods offer over 
biochemical ones employing cell suspensions, homogenates or fractions is 
that they allow an appreciation of the chemical characteristics of individual 
cells and of the heterogeneity of cell populations. Biochemical methods 
yield only a statistical average of the chemical nature of a population of 
cells or of a given subcellular organelle or particulate fraction.
Biochemical analyses of whole organ homogenates give poor estimates of the 
enzyme activity of a single cell type because the cellular population may 
change considerably under different experiments. However, the accuracy 
of histochemical localisation of a substance or enzyme in cells and tissues 
hinges on various factors. In addition to the problems of preserving fine 
structure and chemical identity of intracellular substances, accurate 
localisation depends on the distribution and nature of the substance to be 
studied , the non-specific binding of the histochemical reagent, the 
characteristics of the histochemical capture reaction and, finally, the 
solubility of the reaction end product.
- 65 -
Because of some of the advantages of histochemical over biochemical 
methods of cell localisation of enzymes it was decided to investigate the 
histochemical position of several enzymes including II3-HSD in male rat 
submandibular salivary gland.
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MATERIAL AND METHODS
Submandibular salivary glands were excised from adult male Sprague - 
Dawley rats after killing by cervical dislocation and immediately frozen 
in pulverised solid carbon dioxide. Each gland was sectioned at 10pm in a 
cryostat and the tissue sections mounted on to glass coverslips. For the 
localisation of hydroxysteroid dehydrogenase activity sections were 
incubated separately at 37°C for up to 3 hours, according to the method 
described by Baillie et al. (1966b), in a phosphate buffered medium (pH7.4) 
containing NAB, Nitro B.T. (Nitro Blue Tetrazolium) and substrate. The 
steroid substrates used for the localisation of 11|3-HSD activity were 
cortisol, prednisolone (Sigma, London) and 50C-dihydrocortisol (Mann 
Research Laboratories Inc., New York), each dissolved in dimethyl formamide.
Succinic, «-glycerophosphate, lactic, malic, glucose-6-phosphate and 
3-hydroxybutyrate dehydrogenases were demonstrated by adding the respective 
substrate to the phosphate buffer medium with Nitro B.T. and NAD or NADP 
where necessary. Control sections were incubated concurrently in a medium 
without substrate and upon completion of the incubation the sections were 
washed in water and mounted with an aqueous mountant (Hydromount). The 
remaining histochemical methods for enzyme localisation were taken from 
Pearse (i960):
The histochemical localisation of acid phosphatase in the submandibular 
salivary gland was exhibited by the lead nitrate method of Gomori (1950) 
and the Naphthol AS-MX phosphate method of Burstone (1958c); alkaline 
phosphatase was located by the Naphthol AS-BI phosphate method of Burstone 
(1958a, b); 5-nucleotidase localisation was by the method of Pearse &
Reis (1952); the calcium method of Padykula & Herman (1955) was used for 
adenosine triphosphatase; the Chiquoine method (1953? 1955) was used for 
glucose-6-phosphatase; and the utilisation of esterase by the submandibular 
salivary glands was shown by the Naphthol AS acetate method after Gomori 
(1952a, b).
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RESULTS
No formazan was deposited in the control sections for dehydrogenase 
activity. The results are summarised in Table 9 and Figs. 22-38. 11(3-HSD
activity was not located in any single component of the salivary duct system 
but was evident in striated, lobular and interlobular excretory ducts. The 
dehydrogenase enzymes were localised mainly in the duct epithelium. The 
phosphatases were localised in both the acinar and duct systems except for 
alkaline phosphatase which was localised mainly in the acinar tissue.
Acid Phor.o -
!
i
1. Lead hitrate Method + +
2. NapKthol AS-MX Phosphate
Method 11 ‘V -H-
Alkaline Phosphatase + -
/
5-Nue.l.eotidase _ +  (deposit at 
blood vessel)
Adenosine Triphosphatase + +
Glucose-6-Phosphatase + JLt
Esterase + ++
Succinic Dehydrogenase + -H-
“-Glycerophosphate Dehydrogenase - -H-
Lactic Dehydrogenase + -H-
Malic Dehydrogenase + -H-
Glucose-6-Phosphate Dehydrogenase - ++
3-Hydroxybutyrate Dehydrogenase - -H-
113-Hydroxysteroid Dehydrogenase
1. Cortisol as substrate - -H-
2. Prednisolone as substrate -
3. S^-Bihydrocortisol as 
substrate - -H-
■ 1 » — ■■■!■ ............J>
- enzyme activity absent 
+  weak enzyme activity present
+  enzyme activity present
-H* strong enzyme activity present
Table 9. Histochemical distribution of enzymes in male rat 
submandibular gland.
(x800) HB-Hydroxysteroid dehydrogenase in male rat 
submandibular gland (cortisol as substrate).
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Figure 23. (x2000) Acid phosphatase in male rat submandibular
gland (lead nitrate method).
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(xl900) Acid phosphatase in male rat submandibular 
gland (Naphthol AS-MX phosphate method).

Figure 25. (x2000) Alka] ine phosphatase in male rat 
submaiid i bu 1 a.r g i and.
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(xljOO) 5-Nuclcotidase in male rat submandibular ajrnid.

Figure 27 - (xiOOO) Adenosine triphosphatase in male r 
submandibular gland.

Figure 28. (x9000) Glucose-6-phosphatase in male rat 
submandibular gland.

Figure 29. (xl900) Esterase in male rat submancll bular gland.
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Figure 30« (x900) Succinic dehydrogenase an male rat. 
submandibula r gland.
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Figure 31* (xSjOO) ^-Glycerophosphate dehyd.royenasc in male rat 
submandibular gland.

Figure 32. (x.8800) Lacti c dchycl rogena sc _in_ male rat 
submandibula j ' gland.
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Figure 33« (x9200) Malic dehydrogenase in male rat 
submandibular gland.

(x 8200) Glucose-6-phosphate dchydroacii a s e in 
male rat submandibular gland.

Figure 35. (x7900) B-Hydroxybutyrate dehydrogenase in 
male rat submandibular gland.
-ft
Figure 36. (xll, 400) 11 B-ffydroxys toroid c|c)iydrogenase in
male rat submandibular gland (cortisol as substrate).

Figure 37. (xl0,200) ll3--Hydroxysteroid dchydrogvena.se in 
male rat submandibular gland (5^-dj.hydrocortisol 
as substrate).

(xl2,200) HB-Hydroxvstcroid dehydrogenase in 
male rat submandibular gJand (prednisolone 
as substrate).
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DISCUSSION
The presence of the dehydrogenases in the salivary duct epithelium 
gives proof of the concept of a highly active metabolic duct epithelium.
A high level of succinic dehydrogenase activity has been localised 
in salivary ducts of several species (Hill & Bourne, 1954; Nachlas et al., 
1957; Dewey, 1958) which is indicative of a high metabolic rate and it is 
noted that Telkka et al. (1954) found a diminution in the activity of this 
enzyme, histochemically, following adrenalectomy which could be restored on 
administration of cortisone (Telkka & Kuusisto, 1955)• Succinic and malic 
dehydrogenases are important in the Tricarboxylic Acid Cycle which is 
involved in the central metabolism of the cell. Glucose-6-phosphate 
dehydrogenase is involved in the Hexose Monophosphate Shunt activity which 
can lead to synthesis of ATP and Nucleotides. oc-Glycerophosphate and 
lactic dehydrogenase are involved in early and late glycolysis respectively 
resulting in the synthesis of ATP. $-Hydroxybutyrate dehydrogenase is 
involved in the oxidation of fatty acids leading to active acetate synthesis.
The duct epithelium seems therefore to be active for the transport 
of metabolites into and out of these cells. The existence of II3-HSD 
activity using ring A analogues of cortisol, 5a-dihydrocortisol and 
prednisolone, shows the variation in structures of these substrates does 
not significantly alter 11$-HSD activity. These analogues retain a flat 
ring A/B junction and verify the work of Bush (1956) and Bush et al. (1968).
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SUMMARY
Histochemical studies were performed with a variety of enzymes on male 
rat submandibular gland. The presence of the anaplerotic system enzymes 
and 113-hydroxysteroid dehydrogenase concentrated in the duct epithelium 
gives proof of the concept of a highly active metabolic duct epithelium.
PART IV
AN ATTEMPT TO PRODUCE 11g-HYDROXYSTEROID DEHYDROGENASE 
IN CULTURES FROM THE SUBMANDIBULAR GLAND OF THE
ADULT RAT IN VITRO
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PART IV
AN ATTEMPT TO PRODUCE 11B-HYDROXYSTEROID DEHYDROGENASE 
IN CULTURES FROM THE SUBMANDIBULAR GLAND OF THE 
ADULT RAT IN VITRO
INTRODUCTION
There are three main types of culture methods: a) tissue culture, 
b) organ culture and c) cell culture. In tissue culture and organ culture 
very small fragments of tissue are placed in medium and allowed to develop.
In tissue culture no special precautions are taken and the tissue fragments 
soon become disorganised because of the motility of cells. On the other 
hand, organ culture incorporates special measures to prevent disorganisation 
of the tissue. In cell culture, the tissue is intentionally disorganised 
to produce individual cells, usually by digestion with trypsin.
These cultivation techniques are now widely used in current research 
in the biological sciences. Comprehensive accounts of the development 
and exercise of various procedures of cell and tissue culture are recorded 
by Paul (1970).
The organ culture of the submandibular gland of the adult rat has been 
reported by Trowell (1959) and Tapp (1967). They showed that the cultures 
underwent a series of characteristic changes. The former paper reported 
that pieces of the submandibular gland taken from 60g rats (3-4 weeks old) 
usually remained healthy for up to six days when they were cultured in a 
special medium, T8, and in specially designed culture chambers. Tapp (I967), 
however, chose to use adult rats (12 weeks old). Charreau & Villee (1968) 
have reported on the metabolism of progesterone by rat submaxillary gland 
explants maintained in organ culture.
However, little has been reported on the maintenance of cell or tissue 
cultures from the submandibular salivary gland. The histochemical 
localisation of llg-hydroxysteroid dehydrogenase was found in the duct cells 
(Fig. 22) and it was wondered whether the enzyme might be found in cells or 
tissue cultured from submandibular gland.
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MATERIAL AND METHODS
1. General Preparative Procedures.
A. Preparation of Glassware.
Medicine bottles, pipettes, universal containers, and bottle tops 
were treated according to the following procedures:
All glassware is first rinsed in tap-water followed by an overnight 
soak in 2% RBS 25 (Chemical Concentrates Ltd., London). After a second 
tap-water rinse the glassware is rinsed twice in distilled water and then 
dried completely in a hot oven. Pipettes were rinsed in an automatic, 
syphonic rinser.
The pipettes were sterilised at 160°C for two hours and all other
2
glassware was steam sterilised at 15 lbs./in pressure for 20 minutes.
Bottle tops and liners were treated in the same way as the glassware 
with sterilisation in a pressure cooker.
B. Growth Medium.
Ham!s F12 synthetic defined medium was prepared in the following 
manner. All chemicals, where required, were bought from Flow Laboratories, 
Irvine, Scotland unless otherwise stated.
20^ Hams:
20ml foetal calf serum
8ml Hamfc F12 without sodium bicarbonate
72ml sterile distilled water prepared in laboratory
2ml Hepes buffer
0.6ml sodium bicarbonate (5.6$)
0.5ml glutamine
1.Qml penicillin/streptomycin
C. Balanced Salt Solution.
Hank*s balanced salt solution was prepared in the following manner:
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10ml Hank*s (Flow Laboratories)
90ml sterile distilled water
0.6ml sodium bicarbonate (5-6$)
1.0ml penicillin/streptomycin
D. Trypsin-Collagenase Solution.
(3) Trypsin: 2% in BSS - DVC (Balanced salt solution minus divalent
cations)
(2) Collagenase (highly purified ex Worthington & Co.:-
0.02mg./ml BSS - DVC)
(3) Foetal bovine serum - 11$ in BSS - DVC 
Combine before use:-
2 parts trypsin solution 
4 parts collagenase solution 
2.5 parts foetal bovine serum
E. Trypsin- Versene Solution.
For 100ml of stock versene buffer:
8g sodium chloride (B.D.H.)
0.4g potassium chloride (B.D.H.)
0.2g versene (B.D.H.)
0.02g phenol red (B.D.H.)
This stock is diluted with 900ml of distilled water and 
distributed in J8ml amounts in universal bottles and sterilised 
by autoclaving. These bottles are labelled versene buffer 
solution.
The trypsin-versene stock solution is prepared by diluting 100ml 
of versene buffer stock with 1,900ml distilled water and 5g trypsin 
dissolved in this solution which is sterilised by millipore filter. 
For use 2ml of trypsin-versene stock is added to one universal bottle 
containing the versene buffer solution and the pH adjusted to pH7.6 
with sodium bicarbonate ready for use.
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F. Aseptic Conditions.
The antibiotic incorporation into the balanced salt solution and
growth medium prevents contamination of the gland by micro-organisms.
Further precautions were taken by carrying out growth medium dispensing
procedures in a laminar air flow cabinet. Aliquoting of the fluid was
performed by sterile disposable (Gillette) syringes and needles. All
prepared fluids were filtered through a millipore filter to dispose of any
contaminants in the fluid.
2. Cell Cultivation Procedure.
Adult male (200-250g) Sprague - Dawley rats fed on diet 41B were
killed by cervical dislocation and the submandibular glands removed. The
glands were put in a universal container containing balanced salt solution.
The medium was kept at 37°C until ready for use. The tissue was then
chopped finely and incubated in the trypsin-collagenase solution for 2 hrs.
in a shaking water bath at 37°C. A cell suspension was left, aliquots
having been taken for counting in a haemocytometer, and these cells were
spun at l,000g for 5 minutes to remove the disaggregating enzyme solution.
The pellet of cells was then suspended in the growth medium and portions
were inoculated into the medicine bottles, the total volume being 5ml.
Specimens were taken for staining with 0.1$ trypan blue to ascertain
the viability of the cells, the majority of the cells being viable by this
criterion. The cell cultures were allowed to grow and multiply at
37°C and any flasks requiring changing were trypsinised with trypsin-versene
solution and re-inoculated into further flasks with the growth medium.
Microscopical examination of the cell cultures was performed by use of a
Nikkon inverted light microscope. II3-hydroxysteroid dehydrogenase
6
examination of the cells was carried out by incubating 1x10 cells (removed 
from the flasks by a rubber policeman and centrifuged) in the assay (p. 27) 
instead of the lOOmg. gland homogenate.
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3. Tissue (Explant) Cultivation Procedure.
The submandibular glands were removed and processed as previously 
described under the cell cultivation procedure up to the trypsin-collagenase 
treatment where, instead of this, the chopped tissue (explants) were placed 
into the growth medium in the medicine bottles. Further experimentation 
found that the use of disposable plastic petri dishes was preferable to 
glass medicine bottles. Contamination from the air was prevented during 
the 37°C incubation by sealing the joins on the petri plate with sellotape. 
The medium was changed every 7 days to prevent exhaustion of the growth 
medium. 110-hydroxysteroid dehydrogenases assays were carried out using 
lOOmg. homogenate equivalents (p. 27 ). Incubations with 1ml of the growth 
medium in the 11ml enzyme assay volume were also carried out to find out 
the presence or not of ll$-hydroxysteroid dehydrogenase in the serum of the 
growth medium.
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RESULTS
No 113-hydroxysteroid dehydrogenase activity was observed with cells 
cultured from submandibular salivary gland. Neither 7 day nor 21 day 
explants nor the growth medium exhibited any 113-HSD activity. Therefore 
the possibility that 113-HSD is present in the serum of the growth medium 
can be discounted.
In the cell culture fibroblasts appeared first after 2 days followed 
by the deposition of epithelial cells on the surface of the glass. The 
epithelial cells were cuboidal or rounder in shape than the fibroblasts.
The explants showed fast degeneration and a 7 day old explant culture 
showed up spots of secretory deposit (Fig. 39). The appearance of tubules 
occurs within 7 days as shown in Fig. 40. These tubules can be maintained 
in culture for several weeks and even grow during this period. The culture
of ductal tissue occurs preferentially to acinar tissue (Fig. 41) due to 
the rapid degeneration of acinar tissue. However, a 26 day old explant 
culture showed collagen and enucleated eosinophilic material (probably 
from ductal cell material). This material showed no haemotoxylin stain 
or histochemical enzyme activity (succinic dehydrogenase or II3-HSD).
(x90) 7 days old explant culture of male rat 
submandibular gland showing spots of secretory 
deposit ( s ) .

(x225) 7 days old explant culture of male rat 
submandibular gland showing growth of 1 tubules1 
from the explant.

(x90) Explant culture of male rat submandibular gland 
showing predominance of ductal tissue.
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DISCUSSION
II3-HSD activity has been reported in connective tissue in fibroblast 
cultures in vitro (Berliner & Dougherty, 1961)* Their report indicates 
that cortisol and corticosterone are concentrated by the entire reti­
culoendothelial and connective tissue systems. Portions of these hormones 
undergo metabolism as unconjugated products in these tissues. There is 
also considerable exchange with interstitial fluids, and Samuels (1966) 
has suggested that,with cortisol, extravascular and intracellular binding 
may play an important role. Osinski (i960) also found the placental 
113-HSD strongly bound to connective tissue.
Fibroblastic synthesis results in collagen production, and the effect 
of collagen is relevant to epithelial morphogenesis (Kallman & Grobstein, 
I965, 1966). In the present study, fibroblasts were the first cell type 
to be formed followed later by the appearance of epithelial cells. No
113-HSD activity was seen and it can only be concluded that submandibular 
gland fibroblasts or epithelial cells do not contain the induction processes 
for 113-HSD formation. However, trypsin-collagenase was used in the cell 
isolation and this probably has a detrimental effect on the steroid enzyme. 
The same conclusion can be formed for the explant culture in that the 
induction processes for 113-HSD formation are absent. Several cultures did 
not survive for 2 days but degenerated to loosely packed and shrunken 
cultures, and along with the development of the secretory deposit produces 
evidence that the cultures suffer anoxic stress. This confirms the work 
of Tapp (1967) who tried to reduce anoxia in organ cultures of submandibular 
gland. Anoxia is one of the factors which contributes to the development 
of watery vacuolation when small pieces of the gland are immersed in a 
physiological medium in vitro (Tapp & Trowell, 1967). Ligation of the 
submandibular gland in vivo (Standish & Shafer, 1957; Tamarin, 1971) 
showed that the glands atrophy rapidly. The acinar cells appeared to 
atrophy rapidly whereas the duct cells survived. From these findings one
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can confirm the preferred culture of ducts and tubules by the submandibular 
gland.
There are two main theories as to the reason why the cultures of
submandibular gland did not produce 113-HSD.
1. In the cultures there is anoxic stress which allows fluid to enter 
the cells, some of which may be killed, and, when the oxygen becomes
available, the fluid is secreted causing decrease in cell size and an
accumulation of enzymes, possibly lytic enzymes, in the culture medium.
These changes could be detrimental to the induction of II3-HSD.
2. The disadvantage of cell and tissue culture techniques to their 
employment is the uncertainty that attends the application to the intact 
animal or fresh homogenate of results obtained with cultures. There are 
artificial conditions for the maintenance of viability and the removal of 
cultures from this influence of contiguous and differentiated cells may 
themselves have so altered the homeostasis of the cells in the gland as to 
make comparison with the in vivo cell incorrect. The tissues and cell 
culture are grown in conditions that mimick adrenalectomy, thydroidectomy, 
castration, etc., and although it seems certain th^t the presence of hormones 
is not essential for cell survival it is likely that they are required for 
the full development and function of differentiated cells (Paul, 1970). 
Probably the induction of II3-HSD requires some extraneous cofactors to 
those produced in the cultures.
- 78 -
SUMMARY
1. No 113-HSD activity was observed in cell cultures of rat submandibular 
salivary gland.
2. No llft-HSD activity was observed in explant cultures of rat submandibular 
salivary gland or in serum used in the growth medium.
3. Explant degeneration was followed by the selective growth of sub­
mandibular gland tubules.
4. In the discussion the results are correlated with the reports of 
other workers and two theories are proposed for the absence of 113-HSD in 
the cell and tissue cultures.
GENERAL DISCUSSION
METABOLISM OF 11g-HYDROXYSTEROID DEHYDROGENASE IN 
SALIVARY GLAND
1. In relation to water and electrolyte metabolism.
2. In relation to secretion and interconversion of 
113-hydroxy and 11-oxo groups.
3. In relation to general hormone effects.
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GENERAL DISCUSSION
1. Water and Electrolyte Metabolism.
The adrenocortical hormones are in the widest sense concerned with 
maintenance of homeostasis. They enable the organism to react to internal 
and external stress by sensitising it and calling forth appropriate defence 
reactions, although they are not specific for these reactions.
The corticosteroids show marked differences in the nature and intensity 
of their activity. The distinction between mineralocorticoids and gluco­
corticoids is an unfortunate one since the physiological action of cortisol, 
the most important ’glucocorticoid1, depends much less on its effect on 
carbohydrate and nitrogen metabolism than on its effect on mineral and water 
metabolism. This latter action of cortisol is seen particularly in stress, 
when the most important requirements are maintainance of the circulation, 
fluid balance and renal function. All corticosteroids cause retention of 
sodium and an increase in the excretion of potassium and water but cortisol 
has an additional effect on water metabolism to that of aldosterone and 
deoxycorticosterone. This substance regulates the distribution of water 
and salts in the body independently of the renal excretion of sodium. The 
decrease in water diuresis seen in adrenocortical insufficiency can be 
reversed by administration of cortisol but not of aldosterone. Cortisol 
appears to be necessary for maintenance of a tubular function adequate for 
normal water diuresis but on the other hand does not inhibit the activity 
of the antidiuretic hormone of the posterior pituitary.
Salivary ducts were proposed by the early histologists (Merkel, 1883; 
Werther, 1886) on morphological grounds not to be merely passive conduits 
between the glandular tissue and the oral cavity but were instead responsible 
in some manner for the modification of acinar secretion. The support of 
this suggestion of active ductal tissues was later upheld by the description 
of a rich vascular network surrounding the ducts (Kowalevsky, 1885;
Zimmermann,1898; Flint, 1901; Spanner 1937).
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The ultrastructure of the salivary duct epithelium has indicated, by
the presence of microvilli, secretory antecedents and complex basal
infoldings, that the striated ducts are the principal site of the electrolyte
and water transfer in the salivary duct system (Scott & Pease, 1959;
Leeson & Jacoby, 1959; Parks, 1961; Tandler, 1963), although Tamarin
(1964) indicates that the excretory duct ultrastructure is also compatible
with ion transfer. Parks (1961) has observed a similarity of salivary
gland ultrastructure to that of the renal collecting tubules. The duct
epithelium has a high metabolic activity as shown histochemically by the
high level of enzymes involved in general metabolism (Hill & Bourne, 1954;
Greenspan et al.:* 1964; Ferguson, 1967) and it has been suggested by
Ferguson et al. (1970) that the utilisation of cortisol in striated and
excretory ducts is indicative of II3-hydroxysteroid mediated control of
the composition of saliva by these components of the duct system.
A number of investigators have established that the secretion of
saliva consists of two phases: a primary acinar secretion and a secondary
modification by the duct system which involves water and electrolyte
transfer (Burgen, 1956; Logothetopoulos & Myant, 1956; Burgen & Seeman,
1957? 1958; Langley & Brown, I960; Henriques, 1961; Schneyer & Schneyer,
1961). The electrolyte content of saliva and urine is influenced by
several corticosteroids although mineralocorticoids have been found to
exert a more profound effect than glucocorticoids (Grad, 1952; White et al.,
1955; Martin, 1958; Bates, 1958; Mills, 1966). The salivary
concentrations of sodium and potassium in man vary in a circadian subsystem,
+ +the Na :K ratio being highest just prior to wakening and lowest about mid-day
(Jrad, 1951; Le Traverse & Coquelet, 1952). The relationship noted between
■+■ *t*plasma ACTH (adrenocorticotrophic hormone) and the salivary Na :K ratio means 
that corticosteroids other than aldosterone influence this ratio (Dreizen 
et al., 1952; Grad, 1952). Imrie et al. (1963) discussed the relationship 
between corticosteroids, other than aldosterone, and urinary secretion of
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electrolytes.
There may well be some relationship between the circadian subsystem 
of Na :K and the plasma cortisol level which also exists in a circadian 
subsystem (Peterson, 1957; Poe et al., I960; Mills, 1966). Bates (1958), 
however, could not demonstrate any such connection in human parotid saliva, 
whereas Katz & Shannon (1969a) have shown that parotid fluid corticosteroids 
appear to be a good measure of plasma cortisol. They also demonstrated 
that, when salivary flow is stimulated, the concentration of cortisol plus 
cortisone appears to vary inversely with flow rate resulting in an approxi­
mately constant excretion rate. The II3-hydroxyl group in the steroid 
molecule is unnecessary for a mineralocorticoid effect, but it does exert 
a considerable influence on glucocorticoid function. With the localisation 
of II3-HSB in the salivary gland ducts and other epithelial sites of water 
and electrolyte transport it would seem reasonable to propose that the ducts 
may be the site of a glucocorticoid mediated salivary modification (Ferguson, 
1966).
2. Secretion and Interconversion of 116-Hydroxy and 11-Qxo Groups.
It has been known from circumstantial evidence for a long time that 
cortisol and cortisone interconvert rapidly in the human body. It was 
generally held that the interconversion occurred in the liver (Rosenfeld, 
et al., 1967). 11$-HSP has been shown to have a higher activity in the
livers of many mammalian species while lower activities appear to be present 
in preparations of other tissues (Hurlock & Talalay, 1959; Koemer &
Heilman, 1964). However, although the liver operates extremely effectively 
in the reductive direction, as far as 113-HSP is concerned, the problem to 
account for is that approximately two-thirds of the total major ^21^5 
metabolites of cortisol, or cortisone, in human urine are in the 11-oxo 
form. This leads to the theory that the extrahepatic oxidation of cortisol 
to cortisone is responsible for the major part of the 11-oxo metabolites in 
human urine. The suggestion of Bush (1969) is that the relatively low
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activity of 113-HSD in peripheral tissues would be made up by their large 
mass and the extremely low concentration of cortisone in the circulating 
blood would be explained by the very large, possibly 100^ hepatic clearance 
for cortisone. Bailey & West (1969) have noted that the initial cortisol- 
cortisone interconversion must mainly occur in the general body tissues 
and the speed of interconversion precludes the liver from being the main 
site of interconversion.
The theoiy proposed by Bailey & West (1969) is that the tissues, 
under basal conditions, are receiving from the adrenals approximately equal 
concentrations of cortisol and cortisone. Within the body tissues as a 
whole the cortisol and cortisone are interconverted and metabolised which 
would allow one type of cell to have a raised effective concentration of 
cortisol by making the reaction cortisol-cortisone proceed predominantly 
to the left and another type of cell to have a low effective concentration 
by converting cortisol to cortisone. The submandibular duct cells seem 
to have the latter ability. Bush (1969) postulated the idea of two cell 
types in the liver, assigning the reductive function to the Kuppfer cells 
lining the hepatic sinusoids and the oxidative function to the microsomes 
of the parenchymatous cells. Bush (1956) drew attention to the fundamental 
problem of whether the catalytic actions of adrenal steroids involved a 
cyclic reversible reaction with the hormone or not, and emphasised the 
possible role of the 113-HSD if the former possibility could be substantiated. 
Among the large number of pairs of related 113-hydroxy and 11-oxosteroids, 
the oxo form is systemically active because it is readily reduced to the 
113-hydroxyl by the hepatic 113-HSD. Robel (1971) postulated that in 
hydroxysteroid dehydrogenase action, the metabolites which are inactive by 
themselves could regulate the amount of active hormone available to 
receptors and/or favour its renewal. In the submandibular salivary gland 
the active steroid is that bearing the 113-hydroxyl group rather than the 
11-oxo group. Body weight tends to decrease in rats treated by cortisone
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while nitrogen excretion increases. The most marked catabolic effect is 
observed in lymphoid tissues and muscle but the liver is an exception to 
this inhibitory reaction and in animals treated by glucocorticoid liver 
weight and protein synthesis increases. In the submandibular gland of 
the rat, however, cortisone was found to have no catabolic effect (Zelles 
et al., 1971) whereas on parotid gland there was an intense catabolic effect. 
Organ weight, activity of various dehydrogenases and adenine nucleotide 
contents of submandibular gland were not influenced by cortisone treatment. 
However, Takeuchi et al. (1971) reported that the administration of aspirin 
and cortisone caused significant decreases in most of the components of 
protein-bound carbohydrates of dog submaxillary saliva.
Katz & Shannon (1964) have shown that dog parotid tissue converts 
cortisol to cortisone showing the presence of 113-HSD in the parotid gland 
and the findings of the present study show II3-HSD in submandibular gland. 
Shannon, Katz and coworkers (1959, 1967, 1969a, 1969b) have investigated in 
great detail the presence of free 17-hydroxycorticosteroids (17-OHCS) in 
saliva. The presence of 17-OHCS in plasma is a sensitive index of the 
functional status of the human adrenal cortex. Human parotid saliva 
contains a measurable amount of 17-OHCS and parallels have been demonstrated 
between serum and parotid fluid 17-OHCS levels in both health and disease.
The rapid transfer of cortisol from the bloodstream to parotid fluid suggests 
that parotid fluid steroid measurements possess potential in monitoring 
adrenocortical responses of even a fleeting nature. No glucuronide- 
conjugated steroids, the form used for renal excretion, were present in 
submaxillary fluid suggesting that their secretion is not an excretory 
process. The water solubility of glucuronide conjugates is relatively 
greater than is that of their parent steroids. Such a characteristic 
makes the conjugates more readily available for renal excretion. Thus the 
steroids, mainly cortisol and cortisone, would tend not to subsume an 
excretory function, but rather to participate in a process analogous to the
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enterohepatic circulation. Submaxillary fluid lacks significant corti­
costeroid binding protein activity and therefore free steroid is available 
to the cells of the submaxillary gland.
3. General Actions of Steroid Hormones.
In the last fifteen years or more there have been various approaches 
to the action of steroid hormones. Biochemists and endocrinologists have 
focussed their attention on the control of cellular functions such as 
regulation of enzyme activity by steroid hormone ever since the discovery 
that enzymes are key regulators of metabolic processes. There have
already been extensive reviews on actions of steroid hormones reported
previously (Bush, 1962; Williams-Ashman, 1965; Grant, 1969; Torda, 1971; 
Lang, 1971; Robel, 1971).
Following a stimulating paper by Talalay & Williams-Ashman (1958), 
suggesting that oestrogens act as co-enzymes for the soluble pyridine 
nucleotide transhydrogenase in human placenta, several workers have tried 
to show that enzymes catalysing the conversion of steroid hormones might be 
involved in the action of such hormones. However, data were accumulated 
which seemed incompatible with the general thesis advanced. Hurlock & 
Talalay (1959) were not able to show transhydrogenation with hepatic II3-HSD 
(rat) although the enzyme, like most other HSIHs, can use either NAD or 
NADP as co-enzyme. The II3-HSD in rat submandibular gland can also use 
either NAD or NADP with cortisol as substrate but the inability of cortisone 
to use NADPH or NADH seems to discount any possibility of transhydro- 
genation being related to II3-HSD action in salivary gland.
Yielding & Tomkins (i960) observed that oestrogens can inhibit 
crystalline glutamate dehydrogenase by disaggregating the enzyme molecule 
from a polymeric into a monomeric form. This effect gives rise to the 
concept that hormones may influence enzyme activities through bringing about 
changes in the physical properties of enzyme molecules. The concentrations 
of steroids used in their experiments were far above the physiological levels
- 85 -
and no discernible physiological significance can be shown. Grant (1969) 
has suggested that these studies must be regarded as offering models of how 
steroids might interact with proteins rather than as throwing light on 
physiological processes.
Cyclic AMP (adenosine monophosphate) has been considered as a mediator 
of the hormone effect since Robison et al. (1971) s h o v - i  t-i-.o primary effect 
of hormone action is the activation of adenyl cyclase wnrcn leads to cyclic 
AMP as a secondary messenger and this brings about further secondary events. 
Torda (1971) has stated that the steroid hormones require a two-step 
mechanism (cellular and nuclear) for full expression of the message they 
carry. Steroid hormones pass the cell membranes in a carrier bound form. 
The carrier is either a non-specific translocator, or a specific receptor. 
Thereafter, the hormones are stored in cytosol pools. In order to realise 
their functions they must be remobilised and enter the nucleus in a carrier- 
bound form. A non-specific carrier may act by preparing an allosteric 
binding site of a hormone-specific receptor to bind the incoming steroid 
hormone. When the specific receptor serves as carrier, the steroid hormone 
is either released to form a geneomic coupling on the chromatin, or the 
receptor-hormone-complex becomes attached to the chromatin.
There is considerable evidence that corticosteroids stimulate protein 
and nucleic acid synthesis in liver while the opposite is the case in 
lymphoid tissue. Knox (1951) showed that cortisol induces the liver 
enzyme, tryptophan pyrrolase. The use of protein and RNA synthesis 
inhibitors gave the indirect proof of the induction of new enzyme by 
cortisol. A great deal of work has been concerned with the theory that 
the steroid hormones achieve their effect by influencing genetic expression. 
Lang (1971) has reported that cortisol has a primary action on the nucleus 
and RNA polymerase activity is stimulated which gives rise to an increase 
in RNA synthesis. A part of the newly synthesised RNA can be regarded 
as an RNA which carries the information for the synthesis of specific
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proteins and enzymes.
It is proposed that the 113-HSD in different cellular particles might 
be associated with separate functions. In the mitochondria and membranes 
the action may be with membrane permeability and in the nucleus, as in 
rat submandibular gland, it may be to do with genetic expression.
SUMMARY
- 87 -
SUMMARY
The enzyme responsible for catalysing the oxidation-reduction of the 
11-oxygen functions of steroids is 113-hydroxysteroid dehydrogenase 
(113-HSD). Previous physiological and histochemical studies have shown 
that the enzyme occurs in salivary gland, as demonstrated by the conversion 
of cortisol to cortisone in significant quantities. The aims of this 
thesis were to report more fully on the investigation of llg-HSD in rat 
submandibular gland.
A reverse isotope dilution technique using cortisol-4-^C as substrate 
was used to assay the enzyme in homogenate, spectrophotometric and fluoro- 
metric assays being unsuitable. Cortisol was converted to cortisone, as 
identified by formation of cortisone derivatives and recrystallisation to 
constant specific activity.
A variety of assay parameters were investigated to find the optimal 
conditions of enzyme activity. Nicotinamide adenine dinucleotide was the 
preferred cofactor to nicotinamide adenine dinucleotide phosphate with the 
optimal pH conditions for the cofactor-linked enzyme being pH8.1-8.9 and 
pH7.6 respectively. Both cofactors were in saturating amounts at 1.25mM 
in the assay volume of 11ml. A phosphate buffer showed no side effects 
whereas borate and tris buffer showed chemical reactions and therefore 
phosphate buffer was used to control pH. The optimal temperature for the 
NAD- and NADP-linked llg-hydroxysteroid dehydrogenase was 37°C for 
incubations of 2 mins. and 7 mins. respectively. Km and Vmax values for 
the NAD-linked 113-hydroxysteroid dehydrogenase were 0.48yM and 1.27 n moles/ 
min., the NADP-linked 113-hydroxysteroid dehydrogenase values being 0.95yM 
and 0.37n moles/min. The substrate concentration chosen for enzyme assay 
was approximately 2xKm of the NAD-linked enzyme. Verification of enzyme 
assay for lOOmg gland homogenates was shown by increasingly proportional 
enzyme activity with enzyme (gland) concentration around this value.
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Reversibility of the reaction using cortisone-4-^C as substrate 
could not be shown although reduced cofactors and a variety of pH values 
and incubation periods were used. One of the effects of 113-HSD in 
salivary gland is, therefore, to convert physiologically active steroids 
into inactive steroids by ll$-hydroxyl group transfer to 11-oxo group 
steroids.
Corticosterone, the naturally secreted adrenocorticoid in the rat, was 
metabolised by the submandibular gland II3-HSD.
Rat kidney was also used to investigate 113-hydroxysteroid dehydrogenase 
activity. The conversion of cortisol to cortisone was confirmed but using 
cortisone as substrate it was converted to a product other than cortisol 
thus indicating the difference between kidney and salivary gland metabolism 
of cortisone.
The intracellular localisation of ll£-hydroxysteroid dehydrogenase 
was studied by incubating subcellular particles of the rat submandibular 
salivary gland for the NAD-linked 113-hydroxysteroid dehydrogenase. The 
subcellular particles were isolated from homogenate by differential 
centrifugation in sucrose. The main enzyme activity was found in the 
crude nuclear fraction and this led to the investigation of what part of the 
nuclear fraction was responsible for the enzyme activity. Nuclei were 
isolated using 1.8M Sucrose and these were found to retain the major enzyme 
activity. Attempts to solubilise the nuclear enzyme using detergent and 
hypotonic media were unsuccessful. It is of interest to see that the 
enzyme is nuclear bound as the liver enzyme has been located in the micro­
somal (105,000g/hr.) fraction. The enzyme in the salivary gland may 
influence nucleic acid metabolism. However, further work will have to be 
undertaken to investigate this possibility.
It was recognised that the rat submandibular gland was a tissue of 
differentiated cell types. In the study of 113-hydroxysteroid dehydrogenase 
it was considered important to investigate the activity of the steroid
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enzyme in separated tubules using the enzyme, collagenase, to break up the 
gland. However, little activity was recovered in the tubules probably 
because the collagenase used included a number of protease and peptidase 
impurities.
The histochemical localisation of the enzyme was in the duct cells.
It was not located in any single component of the salivary duct system but 
was evident in striated, lobular and interlobular excretory ducts. Acinar 
tissue did not exhibit any activity. Enzymes involved in central metabolic 
pathways were present principally in the ducts whereas alkaline phosphatase 
was present in the acinar tissue and not in the duct system. Acid 
phosphatase appeared in equal amounts in both the acinar and ductal tissue. 
The presence of these enzymes gives further proof of the concept of a highly 
active metabolic duct epithelium.
The culture of salivary gland ducts was investigated but no 11$- 
hydroxysteroid dehydrogenase activity was present in cultures which were 
7 days and 3 weeks old. The enzyme may require the addition of various 
cofactors and hormones which are lacking in the tissue culture.
NOMENCLATURE
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Steroid Nomenclature: Rules for Nomenclature of Steroids from Biocheru. J .
(1969) 113, 5-28; (1972) 127, 613-617.
Trivial Name 
Adrenosterone 
Ae tio cholanolone 
Aldosterone
Androsterone 
Cholesterol 
Corticosterone 
Cortisol
Cortisone
Cortisone Acetate
11-Dehydrocorticosterone
Deoxycorticosterone
5°^-Dihydrocortisol
20-Dihydrocortisone
11$-Hydroxyandrostenedione
ly^-Oestradiol
Oestrone
Prednisolone
Pregnenolone
Progesterone
Testosterone
Proper Name
4-Androstene-3, 11, 17-trione
3<x_Hydroxy- 5 $-androstan-17-one
18, 11-Hemiacetal of 113, 21-dihydroxy-3, 
20-dioxo-4-pregnen-l8-al
3oc-Hydroxy-5oc -andro s tan-17-one
5-Choiesten-3B-ol
11$, 21-Dihydroxy-4-pregnene-3, 20-dione
118? 17, 21-Trihydroxy-4-pregnene-3,
20-dione
17, 21-Dihydroxy-4-pregnene-3, 11, 20-trione 
Cortisone 2l-acetate
21-Hydroxy-4-pregnene-3, 11, 20-trione
21-Hydroxy-4-pregnene-3, 20-dione
11$, 17, 2l-Trihydroxy-5«-pregnane-3, 
20-dione
17, 20, 21-Trihydroxy-4-pregnene-3, 11-dione 
118-Hydroxy-4-andro stene-3, 17-dione 
1, 3, 5(lO)-Estratriene-3, r/^-diol
3-Hydroxy-l, 3, 5(lO)-estratrien-17-one
118, 17, 2l-Trihydroxy-l, 4-pregnadiene~3, 
20-dione
38-Hydroxy-5-pregnen-20-one
4-Pregnene-3, 20-dione
17 8-Hydroxy-4-andros ten-3-one
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Enzyme Nomenclature (1965) Recommendations 1964 of the International Union 
of Biochemistry, Elsevier, Amsterdam, London, New York.
Trivial Name
Alcohol dehydrogenase
^-Glycerophosphate
dehydrogenase
Lactic dehydrogenase
8-Hydroxybutyrate 
dehydrogenase
Malic dehydrogenase
Glucose-6-phosphate 
dehydrogenase
3oc_Hydroxy steroid 
dehydrogenase
3 (or 17) 8-Hydroxysteroid 
dehydrogenase
Oestradiol 178-hydroxysteroid 
dehydrogenase
Testosterone 178-hydroxysteroid 
dehydrogenase
Testosterone 178-hydroxysteroid 
dehydrogenase (NADP)
Succinic dehydrogenase
Glutamate dehydrogenase 
(NAD(P))
Transhydrogenase
Peroxidase
Tryptophan pyrrolase 
^ “-Hydroxylase
N-acetylglucosaminyltransfer­
ase
Systematic Name
Alcohol: NAD oxidoreductase
L-Glycerol-3-phosphate:
NAD oxidoreductase
L-Lactate: NAD oxidoreducta.se
D-3-Hydroxybutyrate: NAD 
oxidoreductase
L-Malate: NAD oxidoreductase
D-Gluco se-6-pho sphate: NADP 
oxidoreductase
3«-Hydroxysteroid: NAD(P) 
oxidoreductase
3 (or 17) $-Hydroxysteroid: 
NAD(P) oxidoreductase
Oestradiol: NAD 17$- 
oxidoreductase
178-Hydroxysteroid: NAD 
17$-oxidoreductase
178-Hydroxysteroid: NADP 
178-oxidoreductase
Succinate: (acceptor) 
oxidoreductase
L-Glutamate: NAD(P) 
oxidoreductase (deaminating)
Reduced-NADP: NAD 
oxido reducta se
Donor: hydrogen-peroxide 
oxidoreductase
L-Tiyptophan: oxygen 
oxidoreductase
Steroid, reduced-NADP: 
oxygen oxidoreductase 
(17 “-hydroxylating)
UDP-2-acetamido-2-deoxy- 
D-glucose: chitin acetyl- 
aminod e oxygluc o sylt rans fe r- 
ase
Number 
EC. 1.1.1.1. 
EC. 1.1.1.8.
EC. 1.1.1.27. 
EC. 1.1.1.30.
EC. 1.1.1.37. 
EC. 1.1.1.49.
EC. 1.1.1.50. 
EC. 1.1.1.51. 
EC. 1.1.1.62. 
EC. 1.1.1.63. 
EC. 1.1.1.64. 
EC. 1.3.99.1. 
EC. 1.4.1.3. 
EC. 1.6.1.1. 
EC. 1.11.1.7. 
EC. 1.13.1.12. 
EC. 1.14.1.7.
EC. 2.4.1.16.
Trivial Name 
RNA polemic rase
Ali-esterase
Lipase
Acetylcholinesterase 
Alkaline phosphatase
Acid phosphatase
5-Nucleotidase
Glucose-6-phosphatase
a-Amylase
$-Amylase
Lysosyme
8-Galactosidase
$-Glucuronida s e
Amino peptidase
Trypsin 
Collagenase 
ATP ase 
Aldolase
Carbonic anhydrase 
Steroid A-isomerase
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Systematic Name
Nucleosidetripbosphate: RNA 
nucleotidyltransferase
Carboxylic-ester hydrolase
Glycerol-ester hydrolase
Acetylcholine hydrolase
Orthophosphoric monoester 
phosphohydrolase
Orthophosphoric monoester 
pho sphohydrolas e
5-Ribonucleotide 
pho sphohydrola s e
D-Gluco se-6-pho sphate 
pho sphohyd rola s e
<r-l, 4-Glucan-4-glucano- 
hydrolase
cc-1, 4-GIucan maltohydrolase
Mucopeptide N-acetyl- 
muramylhydrolase
$-D-Galactoside 
gala c t ohydrola s e
$-D-Glucuronide 
glucuronohydrolase
Amino-acyl-oligopeptide 
hydrolase
ATP phosphohydrolase
Ketose-1-phosphate 
aldehyde-lya s e
Carbonate hydro-lyase 
4 ^3-oxosteroid A -A 
isomerase
Number
EC. 2.7.7-6.
EC. 3.1.1.1. 
EC. 3.1.1.3. 
EC. 3.1.1.7. 
EC. 3.1.3.1.
EC. 3.1.3.2.
EC. 3.1.3.5.
EC. 3.1.3.9.
EC. 3*2.1.1.
EC. 3-2.1.2. 
EC. 3.2.1.17.
EC. 3.2.1.23.
EC. 3.2,1.31.
EC. 3.4.1.2.
EC* 3*4>4-*4* 
EC. 3.4.4.19. 
EC. 3*6.1.3* 
EC. 4.1.2.7.
EC. 4.2.1.1. 
EC. 5.3.3.1.
Other Nomenclature
Where abbreviations occur in the text of the thesis, the proper names have 
been inserted alongside the first quotation to them. Those not inserted 
in the text of the thesis are:
Trivial Name 
Naphthol AS acetate 
Naphthol AS-BI 
Naphthol AS-MK
OV-17
Tris hydrochloride
Proper Name
2-Acetoxy-3-naphthoic acid anilide
6-Bromo-2-hydroxy-3-naphthoyl-0-anisidine
3-Hydroxy-2-naphtho-2, 4-xylidide
Phenyl methylsilicone, 50$ phenyl
Tris (hydroxymethyl) aminomethane hydrochloride 
(Tris; THAM: 2-Amino-2-(hydroxymethyl)-l, 3- 
propanediol)
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